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Science is a partial means to the understanding of the ultimate
question of life, the universe, and everything.
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INTRODUCTION

This dissertation is a study of the effects of pyridonecarboxylic
acid derivatives (quinolones) on Pseudomonas aeruginosa.

These drugs

are important to study because the newer, more potent derivatives are
effective against gram negative infections (30,34) such as

f.

aeruginosa

which is an opportunistic pathogen of burn wounds and the lungs of
children with cystic fibrosis (2,13,14,32,66).

Norfloxacin, a newer

derivative, which is more potent than oxolinic acid and nalidixic acid,
has not yet been studied in P. aeruginosa.

Since the effects of

oxolinic acid and nalidixic acid on Escherichia coli have been well
studied

(e.g.,

19),

it is

beneficial

to compare the effects of

norfloxacin, oxolinic acid, and nalidixic acid on P. aeruginosa.
Pyridonecarboxylic acids act by binding to DNA (70) and inhibiting
the activities of DNA gyrase and of one of its two subunits (termed A)
which also interacts with another protein to form Topo II'

(6).

Therefore, in order to understand the mechanism of drug action, the in
vitro effects of these derivatives on P. aeruginosa DNA gyrase and its A
subunit will be studied.

1

REVIEW OF THE RELATED LITERATURE

SUPERHELICAL DNA

The bacterial chromosome consists of a closed circular double helix
of DNA that is maintained in an underwound topological state.

The

twisting of the DNA helix either into an underwound or an overwound
state

is

termed

respectively.

negative

supercoiling

or

positive

supercoiling,

The degree of supercoiling is described by the following

relationship:
T=L-L 0

1.

where T is the number of titratable superhelical turns, L is the number
of times that one strand of the double helix crosses over the other
strand, termed the linking number, and L0 is the linking number of
relaxed (not twisted) DNA.
In nature, DNA is found in a negatively supercoiled state (L<L 0 )
which promotes single strandedness. This negative superhelicity has
been shown to be required for replication, transcription, recombination,
repair of DNA, and plasmid maintenance (reviewed in 10, 24, and 85).
Positively supercoiled DNA (L>L 0 ) can be generated in vitro, however no
biological significance has been found for overwound DNA.

2

DNA TOPOISOMERASES
How

does

the

chromosome

become

negatively

supercoiled?

Environmental parameters such as ionic strength, temperature, and the
concentrations of certain DNA binding ligands affect the number of
primary twists per DNA molecule. Therefore, the value of L0 in equation
1 will vary depending on the environmental conditions in which the DNA
is formed (reviewed in 18).
The other factor that determines superhelicity of DNA is the
concerted activity of a class of enzymes termed DNA topoisomerases.
Topoisomerase I relaxes negative supercoils by breaking one strand of
the duplex and releasing one supercoil (L) at a time.

Topoisomerase II

(DNA gyrase) supercoils the chromosome by binding DNA at two places,
breaking both strands of one of the bound portions and passing the other
bound portion through the break (Figure 1), thus decreasing L by two for
each reaction (24).
The activities of topoisomerases I and II in the cell are balanced
to maintain an optimal

level of superhelicity of the chromosome.

Mutations in Escherichia coli topoisomerase I result in an increase in
negative superhelical density in both the bacterial chromosome and
plasmid pBR322.

Some strains containing topoisomerase I mutations,

however, have decreased negative superhelical density.

These mutants

have developed secondary mutations in DNA gyrase that compensate for the
pres~mably

intolerable level of superhelical density caused by the

deficiency in topoisomerase I (66).
The homeostatic control of DNA supercoiling by topoisomerase I and
DNA gyrase regulates the expression of the

f.

coli DNA gyrase gene.

4

0
DNA gyrase binds better to relaxed DNA
than it does to supercoiled DNA.

The DNA wraps around DNA gyrase in a
positive (+) sense creating negative
(-) supercoild elsewhere in the DNA.

DNA gyrase reseals the break
on the front side.

DNA gyrase makes a double-stranded
break in the back segment.

Figure 1. The Supercoiling Reaction of DNA Gyrase

5

Addition of exogenous topoisomerase I to an S-30 in vitro protein
synthesizing system stimulates synthesis of DNA gyrase (52).

This

stimulation is probably due to a decrease in the negative superhelical
density and not to any direct role of £_. coli topoisomerase I as a
regulatory protein, since addition of exogenous Hela cell topoisomerase
I (a eukaryotic enzyme) to this system also stimulates DNA gyrase
synthesis (52).

Treatments that block DNA gyrase activity and decrease

the superhelical density of intracellular DNA result in as much as a
10-fold increase in the in vivo synthesis of both the A and B subunits
of DNA gyrase (52).

Thus, relaxation of the chromosome stimulates the

synthesis of DNA gyrase and results in an increased capability of the
cell to supercoil DNA.

Conversely, increasing the superhelical density

of the chromosome decreases the synthesis of DNA gyrase and results in a
decreased capability of the cell to supercoil DNA.

It is not known if

the expression of the topoisomerase I gene is affected by the degree of
supercoiling as well.
DNA gyrase is made up of two subunits (A and B) which map
separately on the E. coli chromosome (29,62).

The holoenzyme, which has

a molecular weight of 400,000, consists of two A subunits (MW 105,000)
and two B subunits (MW 95,000) (29,62).

vitro there are seven
-In ---

different reactions catalyzed by DNA gyrase as a holoenzyme or by one of
the subunits alone (Figure 2):

1.

Both subunits are required for negative supercoiling of a

closed DNA duplex in a processive reaction that required ATP and
Mg++, and that is stimulated by spermidine (10,21,22,29).
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1.

0

ATP

Gyrase

0

2.

~

3..

DNA+Gyrase

4.

,

DNA·Gyrase

oxo
Gyrase

NaDodSO~

Duplex DNA

5.

ATP

ADP

+

Pi

Spermidine.

6.

~

7.

oovo

J!TP+Gyrase

~
~

~ T P+.Gyrase

Figure 2. The Activities of DNA Gyrase.
The reactions illustrated are supercoiling (reaction 1), relaxation
(reaction 2), binding (reaction 3), cleavage (reaction 4), ATPase
(reaction 5), catenation and decatenation (reaction 6), and knotting and
unkotting (reaction 7). The DNA substrate is shown as relaxed, closed
circular DNA for reaction 1, negatively supercoiled DNA for reaction 2,
6, and 7, and as linear DNA for reaction 4. Oxolinic acid is
abbreviated OXO and sodium dodecyl sulfate as NaDodS0 4.
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2.

The A subunit will relax negatively supercoiled ONA in the

absence of ATP (22,23,46,77).

In the presence of oxolinic acid (an

inhibitor of the A subunit),

~

less that one percent of the

supercoiling reaction products consists of cleaved linear ONA (77).
3.

The ho l oenzyme binds to ONA about every 100 ki l obase pairs.

About 140 base pairs of ONA wrap around the outside of the enzyme
in a positive coil creating counterposing negative supercoils
elsewhere in the ONA (29,39,62).

DNA gyrase binds better to

relaxed DNA than it does to supercoiled DNA (10).

Using electron

microscopy, the A subunit has been visualized to bind to DNA in the
absence of the B subunit (62).

Electron micrographs of ONA gyrase

from M. luteus shadowed with platinum show a heart shaped molecule.
When these molecules are complexed with ONA, two binding modes are
observed, one in which the 1ength of the bound ONA is shortened,
termed the full binding mode, and a second in which the length of
the bound DNA is unaltered, termed the incomplete binding mode
{38).

4.

The ho 1oenzyme cl eaves the ONA by forming a phosphotyros i ne

bond between the 5'-hydroxyl of each strand and the A subunit (79).
This can be seen in vitro by incubating DNA gyrase and DNA with
oxolinic acid, followed by treatment with sodium dodecyl sulfate
(SOS).

Cleavage is observed in the absence of SOS, but SOS

treatment increases the fraction of cleaved molecules from less
than one percent to 41 percent.

The same pattern of cleavage is

observed when ONA gyrase isolated from£. coli, Micrococcus luteus,
Bacillus subtilis, or a combination of subunits

from~·

coli

and~·

8

luteus is used (6,61,76,77).

ATP alters the cleavage pattern by

stimulating cleavage at some sites and reducing it at others (77).
5. The B subunit hydrolyzes ATP into ADP and Pi in the presence of
duplex DNA (58,77).
6.

The holoenzyme can catenate and decatenate DNA rings in the

presence of ATP.

Catenation requires spermidine and decatenation

requires the absence of spermidine (2).

7. The holoenzyme can also unknot and knot DNA in the presence of
ATP ( 10,43).
The subunits of DNA gyrase are most likely in equilibrium with the
complete protein, since the addition of the A subunit to DNA gyrase
stimulates its supercoiling activity and addition of drug resistant A
subunit to DNA gyrase renders the supercoiling activity resistant to the
drug.

TOPO II

I

The A subunit of DNA gyrase can also bind with another protein,
termed v, to form topo II'.

The v subunit which consists of a single

50,000 dalton polypeptide appears to be a proteolytic product of the B
subunit, since their polypeptide maps show substantial similarity (6).
Topo II' has three activities in common with DNA gyrase; relaxation of
negative supercoils, wrapping of the DNA substrate around it in a
positive coil, and cleavage of DNA at specific sites in the presence of
oxolinic acid (reference 4, and activities 2, 3, and 4 from the previous
section). Although the cleavage patterns of topo II' and DNA gyrase are
the same, topo !I's pattern is not altered by ATP as is the pattern of

9

DNA gyrase (6,77).

Topo II' possesses one activity that DNA gyrase

lacks; it will relax positive supercoils.
require ATP.

This activity does not

Neither subunit A or v by themselves will relax positive

supercoils (6).

It appears that subunit v results from the cleavage of

the portion of the B subunit that contains the ATPase activity.
Brown

et~·

(6) noticed that DNA relaxed by topo II' has a higher

electrophoretic mobility than DNA gyrase-relaxed DNA.

This increased

mobility is due to positive supercoils present in the topo II' relaxed
DNA to an extent depending stoichiometrically on the ratio of enzyme to
DNA.

They suggest that the reason for this is that topo II', like DNA

gyrase, wraps the DNA substrate around itself in a positive coil which
creates counterposing negative supercoils elsewhere in the DNA.

Topo

II' unlike DNA gyrase will relax these negative supercoils, leaving
positively supercoiled DNA.
It is suspected that 1ess pure preparations of DNA gyrase are
contaminated with this relaxing enzyme, because as the purity of DNA
gyrase is increased, the ratio of oxolinic acid-sensitive relaxation
activity to oxolinic acid-sensitive supercoiling activity declines to a
nonzero plateau value (29,62,77; i.e., there is an excess of relaxation
activity over supercoiling activity).

The contaminating

relaxing

activity cannot be due to topoisomerase I, since this enzyme is not
sensitive to oxolinic acid (24).

Since topo II' can relax positive

supercoils, the ability of less pure DNA gyrase preparations to relax
positive supercoils (22,77) and the disappearance of this activity upon
further purification (6) can be explained.
There are three known

f.

coli topoisomerases (compared in table 1):

topoisomerase I, topoisomerase II (DNA gyrase}, and topoisomerase II'.

10

Table 1.

~·

Topo II (gyrase)

Topo II

Monomer

A

B

A

v

110

105

95

105

50

Unknown

~ ~

Property

Topo I (w)

Subunits
Proto~er

(x 10 )

Mw.

Structural
gene

coli Topoisomerases

I

~ ~?

Activities:
Relaxation of
(-) Supercoils

Yes

Yes

Yes

Relaxation of
(+) Supercoils

No

No

Yes

Introduction of
(-) Supercoil s

No

Yes

No

Stoichiometric
( +) Supercoi 1
Introduction

No

No

Yes

DNA Wrapping
around Enzyme

None

(+)

( +)

DNA Sitespecific Binding

Some

Yes

Yes

Dena tu rantinduced DNA
breaks

Singlestrand

Doublestrand

Doublestrand

11

All relax negative supercoils, with topoisomerase I possessing the
greatest total detectable activity, topo II' the next most, and DNA
gyrase the least (6). Only DNA gyrase can negatively supercoil DNA, and
only topo II' can relax positively supercoiled DNA (6).

ANTIBIOTICS THAT AFFECT DNA GYRASE AND TOPO II'

The activities of the B subunit are inhibited by coumermycin Al and
novobiocin (reviewed in 20 and 24). These antibiotics cause a reduction
in the superhelical density that closely parallels an inhibition of DNA
synthesis, i ndi ca ting that the decrease causes the i nhi bi tion of DNA
syn thesis (16).
Pyridonecarboxylic acid derivatives (e.g., nalidixic acid, oxolinic
acid, and norfloxacin, Figure 3) are antimicrobial drugs effective
against most gram negative bacteria.

These drugs inhibit DNA synthesis

by inhibiting the activities of the A subunit (10).
readily reversed by removal of the drug.

This inhibition is

Engle et 2l_. (19) have

suggested that these drugs inhibit DNA replication by forming a tight
complex between the A subunit and DNA which inhibits replication fork
migration.

Upon treatment with the drug,

inhibition of DNA synthesis.

there

is an immediate

Recovery synthesis following inhibition is

possible in wild type strains of E. coli but not in mutants deficient in
recombinational repair of DNA (19).
Recent evidence shows that pyridonecarboxylic acids bind to DNA and
not the DNA gyrase (70).

They bind preferentially to single-stranded

DNA rather than the double-stranded DNA.

The calculated apparent Kd

values of the different derivatives correlate well with their Ki values

0

0

COOH

CO)H

Nalidixic Acid
Mw. 232.2

Oxolinic Acid
Mw. 261

Norfl oxaci n
Mw. 319.33
.....
N

Figure 3.

The Chemical Structures of Pyridonecarboxylic Acid Derivatives.
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(i.e., the more potent the inhibitor, the greater it binds to DNA).
Shen et

~·

(70) proposed that DNA gyrase translocates along the DNA or

DNA segments translocate through gyrase until the DNA gyrase comes to
the bound drug molecule and forms a ternary complex that is more stable
than the binary DNA gyrase-DNA complex.
Inhibition of DNA synthesis in

~·

coli by pyridonecarboxylic acids

has been shown to have biphasic kinetics in the absence of DNA repair or
initiation of new rounds of DNA replication (17).

There is an initial

rapid rate of inhibition followed by a slower rate of inhibition.

If

the drug-DNA gyrase complexes occurred only at 100 kbp intervals, then
monophasic kinetics would be expected.

The fact that oxolinic acid and

SOS treatment induces additional cleavage in pulse-labeled DNA as
opposed to long term-labeled DNA (17), indicates that DNA gyrase binds
at or near the replication fork in addition to its binding at about 100
kbp

intervals.

The

initial

rapid

inhibition

observed

in

pyridonecarboxylic acid treated E. coli cells may be due to inactivation
of gyrase at or near the replication forks.

Some replication forks may

have escaped the drug and the second slower rate of inhibition may be
due

to

these

replication.

replication

forks

proceeding

to

the

terminus

of

Increasing the number of inactivated DNA gyrase sites by

increasing the concentration of pyridonecarboxylic acids causes an
increase in the initial rapid rate of inhibition but does not change the
slower rate of inhibition (17).

This suggests that the replication

forks are not stopped by drug-DNA gyrase complexes located at 100 kbp
intervals (17) •
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DNA REPAIR AND RECOVERY SYNTHESIS IN E. COLI

There are four DNA repair pathways known to exist

in~·

coli (82).

These pathways are called photoreactivation, SOS processing, excision
repair, and postreplication recombination (Table 2).
Photoreactivation specifically repairs the most common effect of
ultraviolet irradiation on DNA, the thymine dimer.

A thymine dimer,

results from the covalent cross-linking of two thymine bases located
adjacent to each other on the same strand of DNA.

The photoreactivation

enzyme binds to a dimer and directly cleaves the crosslink in a
light-dependent reaction (82).

Therefore, in order to study the other

three DNA repair pathways without interference of photoreactivation,
experiments must be conducted in the dark.
The three dark repair pathways have the recA gene in common.

The

product of the recA gene is a protein that regulates the expression of
SOS processing and one of the two modes of excision repair.
an integral part of recombinational repair.

It is also

A double mutant deficient

in both excision repair and the recA function has virtually no DNA
repair capacity in the absence of visible light (82).
SOS processing is part of the SOS response that occurs when the
protease activity of recA protein is induced by a DNA damaging agent
such as ultraviolet light or nalidixic acid.

The recA protease acts by

cleaving a repressor protein coded for by the lexA gene.

This lexA

repressor binds to the control regions of the genes involved in the SOS
response (Table 2) and prevents their expression.

Cleavage of the lexA

repress or by the recA protein allows the expression of the SOS genes
until the DNA damaging signal is gone and the recA protease function is

Table 2. The Genes Involved in the SOS Response

DNA Repair
Pathways

E. coli
-Genes

Removes
Lesions

Replication
Dependent

Inducible

Mutagenic

Photoreactivation

phr

Yes

No

No

No

Excision Repair

uvrA, uvrB,
uvrC, uvrE

Yes

No

Yes*

No

Postreplication
Recombination

recA,
recC,
sbcB,
recF,
recK

recB,
sbcB,
recE,
recJ,

No

Yes

Yes

No

umuC, umuD,
lon, mut,
dam, 1exA

No

Yes

Yes

Yes

SOS Processing

*The short patch repair mode is constitutive.
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no longer active.

Not much is known about the SOS processing repair

pathway except that it is error-prone {or mutagenic) and that it occurs
during replication.

It appears that during replications, SOS processing

functions will pair any base with a damaged base.

Since there is a

three out of four chance that the wrong base will be paired with the
damaged base, mutations will result from this type of repair (82).
The excision repair pathway repairs DNA by removing a portion of
the strand of DNA that contains the damage.

Ninety nine percent of the

time, a section of approximately 20 bases is cleaved in the short patch
repair mode, which is a constitutive function of the cell.

In the other

one percent of the time, a section of about 1500 bases will be cleaved
in long patch repair, a mode which must be induced by the recA protease.
This repair must occur before replication can continue since the damage
poses as a barrier to the migration of the replication fork (79).
Postreplication recombination is useful when the cell has acquired
a large amount of damage and does not have enough time to repair the DNA
before replication has to be completed.

DNA polymerase will bypass the

damage and leave a gap in the complementary strand.

The damage and

resulting gap will be repaired later when the cell has the time and
energy.

The gap is filled with a strand from the complementary DNA

molecule, leaving one molecule with the damage and the other with a gap.
Now each DNA molecule has one good strand that can be used as a template
for synthesizing a complementary strand (82).
The recovery syn thesis seen in E_. col i after i nh i bit ion of DNA
synthesis by pyridonecarboxylic acid derivatives is not affected by
mutations that render the cell deficient in excision repair (19).
Recovery synthesis does not occur in mutants with defects in the recA or
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lexA genes (19).

Since the short patch repair mode of excision repair

is not regulated by the recA protein (82), and since the drug-DNA gyrase
complex is longer than twenty nucleotides (the length of DNA excised in
the short patch repair mode), the short patch repair mode can be ruled
out as the repair process used to remove the drug-DNA gyrase complex.
Nalidixic acid has been shown to induce protein X, which has been
identified

as

(25,26,29,30).

the

protein

product

of

the

E.

coli

recA

gene

It also has been shown to induce error-prone repair of

UV-irradiated phage 9}X174 DNA

in~·

coli (67).

However, little or no

induction of recA occurs at low concentrations of oxolinic acid where
inhibition and recovery synthesis still occur (19).

Perhaps there are

enough low constitutive levels of recA protein present in the wild type
cell to remove the drug-DNA gyrase complex from the DNA.
repair mechanism that

~·

The exact DNA

coli uses to recover from inhibition of DNA

synthesis by pyridonecarboxylic acid derivatives is still unknown.

BACTERICIDAL ACTIVITY OF PYRIDONECARBOXYLIC ACID DERIVATIVES

Inhibition of DNA synthesis may not be the cause of death in cells
treated with pyridonecarboxylic acid derivatives.

Optimal bactericidal

concentrations of these drugs cause almost 100% inhibition of DNA
synthesis but still allows some RNA and protein synthesis to occur (76).
At higher concentrations, RNA and protein synthesis are inhibited to a
greater extent and the drug is no longer as potent.

Competent RNA and

protein synthesis are required for killing, since their inhibition will
reverse the bactericidal effects of pyridonecarboxyl ic acids (76,83).
These results have led Stevens (76) to propose that the mechanism of
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drug-induced death was due to an imba 1ance between DNA and protein
biosynthesis

which

leads

to

filamentation.

This

drug-induced

filamentation results from the growth of the cell due to continued RNA
and protein synthesis when cell division is inhibited due to inhibition
of DNA replication.

In support of this model, he noted that drug

resistant mutants did not experience inhibition of DNA synthesis until
high enough concentrations of the drug that RNA and protein synthesis
were also inhibited.
specific

event

He also noted that cell death may be due to a more

since

hydroxyurea

also

induces

filamentation

by

inhibiting DNA synthesis while allowing RNA and protein synthesis to
continue but does not cause cell death (76).
Additional

research has also suggested that the mechanism of

drug-induced cell death may be more complex.
culture of logarithmically

growing~·

A norfloxacin treated

coli cells will almost immediately

lose their viability, but some will grow and divide, while others will
filament (11).

This lethal unbalanced growth could result from the

prevention of the completion of a round of chromosome replication by
norfloxacin, since a round of chromosome replication may trigger the
initiation of septation which precedes cell division (15).

Lethal

unbalanced growth is also seen in !!_. subtilis cells during thymine
starvation or treatment with ionizing radiation (5).

These treatments

inhibit DNA replication but do not inhibit RNA or protein synthesis (5).
Several laboratories have shown that inhibition of DNA gyrase
causes differential effects on specific gene expression (summarized in
table 1 or reference 18).

The differential effects on gene expression

may be the actual cause of drug-induced death.

For instance, inhibiting

DNA gyrase results in a decrease in the synthesis of outer membrane
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proteins as opposed to inner membrane proteins (28).

The rate of

synthesis of inner membrane proteins increases exponentially throughout
the cell cycle (63,64).

The rate of synthesis of the outer membrane

proteins is constant in the early part of the cell cycle, but doubles
abruptly just before cell division (63,64).
this

abrupt

increase

might

be

It has been proposed that

sufficient

to

initiate

surface

invagination and trigger septum formation and cell division (63,64).
Therefore, by inhibiting the expression of outer membrane proteins,
pyridonecarboxylic acid derivatives may prevent cell division.

DNA GYRASE AND GENE EXPRESSION

Genes coding for membrane proteins are not the only ones affected
when DNA gyrase is inhibited.

Inhibition of gyrase with nalidixic acid

causes a decrease in expression of catabolite-regulated operons (66).
A catabolite-regulated operon in E. coli is one that is turned off
when glucose is present in the medium.

~·

coli metabolizes glucose in

preference to other sugars such as lactose, galactose, and arabinose.
In the presence of glucose,

~·

coli will repress the expression of the

operons that code for the enzymes that metabolize these other sugars.
The binding of a protein termed catabolite activator protein (CAP) to
the control region of catabolite-regulated operons is required for their
expression.

The CAP protein, in turn, must interact with eye 1i c AMP

(cAMP) to be able to bind to DNA.

Glucose prevents the expression of

catabolite-regulated operons by reducing the levels of cAMP in the cell.
The reduction in expression of catabolite-regulated operons by nalidixic
acid does not seem to be mediated through alterations of the cAMP
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concentrations in the cell, since addition of exogenous cAMP does not
reverse the effects of nalidixic acid (71).
The more sensitive an operon is to catabolite repression, the more
its expression is reduced in the presence of nalidixic acid.

The

express ion of the tryptophanase gene and the three maltose operons,
which are all very sensitive to catabolite repression, is also strongly
inhibited by nalidixic acid, whereas the lactose operon displays a lower
sensitivity to both catabolite repression and nalidixic acid.

The

threonine and tryptophan operons, which are insensitive to catabolite
repression, are also insensitive to nalidixic acid (68).
Smith et

~·

(73) found that expression of the tryptophan operon is

inhibited by novobiocin and nalidixic acid when it is under the control
of the lambda phage PL promoter, but not when it is under the control of
its own promoter.
(71).

Transcription from PL is inhibited by phage repressor

This is another instance where an operon whose transcription is

affected by a regulatory protein is repressed by nalidixic acid, while
an operon whose transcript ion is unaffected by regulatory proteins is
not repressed by nalidixic acid.
Genes under the control of the tryptophan promoter require coupling
between the translational machinery and RNA polymerase for continued
transcription, while genes under the control of the PL promoter do not
require this coupling (33).

This indicates that there may be a

relationship between the repression of a gene by pyridonecarboxylic
acids and how closely it is coupled to translation.
Novobiocin and pyridonecarboxylic acids have been shown to have a
similar effect on transcription from specific operons (69,72,85), but
they have different effects on the synthesis of the protein products of
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these specific operons

(81).

In B.

subtilis,

novobiocin greatly

inhibits the synthesis of alkaline phosphatase and histidase.

It

inhibits the synthesis of protease to a lesser extent and has no effect
on amylase synthesis (81), whereas, pyridonecarboxyl ic acid severely
inhibits only alkaline phosphatase synthesis (81).

This difference

between the two types of drugs indicates that they may effect gene
expression through different mechanisms.
The selective inhibition of gene expression by novobiocin and
coumermycin Al is most likely a result of the decrease in negative
superhelical density caused by these drugs (37).
earlier, decreasing the superhelical density of the

As was mentioned
~·

coli chromosome

by addition of exogenous topoisomerase I will stimulate the expression
of the DNA gyrase gene in vitro (52).

DNA gyrase synthesis can also be

stimulated up to 10-fold by treatment with coumermycin Al or novobiocin,
which block DNA gyrase activity and decrease the supercoiling of
intracellular DNA (52).

It appears

that changing the degree of

supercoiling by inhibiting DNA gyrase will have a positive effect on the
expression of some genes and a negative effect on others.

The change in

superhelical density may alter the shape of binding sites of regulator
proteins, such as contra 1 regions and promoters, and thus a1ter the
affinity of the control proteins, such as CAP and RNA polymerase, for
these sites.
Pyridonecarboxylic acid derivatives may effect gene expression
through a different mechanism, because the reduction of gene expression
by oxolinic acid does not parallel the decrease in superhelical density
caused by the drug (51).

The selective inhibition of gene expression
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may be caused by the drug-DNA gyrase complexes spread throughout the
genome (74).

PSEUDOMONAS AERUGINOSA DNA GYRASE AND TOPO II'

P. aeruginosa is not inhibited by most pyridonecarboxyl ic acids
(34), and DNA gyrase from

f.

aeruginosa is more resistant to inhibition

by nalidixic acid than is gyrase from £_. coli (56).

Norfloxacin,

however, has been shown to be an effective antimicrobial agent against

f.

aeruginosa (30,34).

In general, norfloxacin is more potent and acts

against a broader spectrum of bacteria than other pyridonecarboxyl ic
acids (30,34).

Also, norfloxacin treatment reduces the amount of

enterotoxin transported into the periplasm of £_. coli cells (11).
Often, the symptoms of patients with bacterial infections are caused by
specific proteins such as enterotoxin, which are excreted by the
invasive bacteria.

Therefore, norfloxacin may also have a value in the

symptomatic relief of patients.
In this dissertation, norfloxacin will be studied and compared to
other

pyridonecarboxylic

acid

derivatives.

Previous

studies

with

pyridonecarboxylic acid derivatives have dealt mostly with£_. coli, a
bacterium commonly found in the human gut.
with

f.

This dissertation will deal

aeruginosa, a soil bacterium that has been increasingly detected

as an opportunistic pathogen in patients suffering from trauma (2),
burns (14), and cystic fibrosis (13,14,31,32).
gyrase and topo II' from

~·

The A subunit of DNA

coli has been very well characterized

(10,16,17,18,20,21,22,23,24,29,37,39,43,48,49,52,58,59,60,61,62,75,77}
while little is known about P. aeruginosa A subunit (56).

METHODS

STRAINS AND MEDIA

All strains (Table 3) have been derived from the prototrophic
strain PAOl (67), and were maintained in Luria broth (55).

Rec- strains

are deficient in recombinational repair and Les- strains are deficient
in prophage lysogeny establishment (Table 3). The norfloxacin resistant
strains are spontaneous mutants (i.e., not exposed to mutagens).

They

were isolated by incubating strain RM9 in 10 tubes containing high
concentrations of norfloxacin.

One clone was isolated out of each of

the four tubes exhibiting growth.

f·

coli DNA gyrase was isolated from

strain H560 (polA, endA) which was a gift from Dr. Martin Gellert (22).
All experiments were carried out in Pseudomonas Minimal Medium (57)
containing 0.4% glucose and 0.01% arginine.

All drugs were freshly

prepared from each experiment at 100-fold greater than the desired final
concentration.

Norfloxacin (gift of Merck, Sharp, and Dohme), nalidixic

acid (Sigma), and oxolinic acid (Sigma) were dissolved in .01 N NaOH and
novobiocin in water.
ethanol.

Chloramphenicol and rifamycin were dissolved in

Phage D3 and plasmid pME299 were gifts from Dr. Bruce W.

Holloway and Dr. Dieter Haas, respectively.
Amersham.
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9'X174 was purchased from
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Table 3.

P. aeruginosa Strains Used in This Study

Strain

Genotype

PA0303

argB21

RMB

argB21, lesB908

PA02001

arg-32, spr-39

PA02003

arg-32, spr-39,
and rec-1

Relevant Phenotypes
Rec+
Rec Rec +
Rec
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MIC'S AND MBC'S

The

minimal

inhibitory

concentrations

(MIC's)

and

minimal

bactericidal concentrations (MBC's) were determined as follows.

A

series of test tubes containing varying concentrations of antibiotic in
Mueller-Hinton broth were inoculated with 106 bacteria per ml and
incubated at 37° C.

The minimum concentration at which growth visible

with the naked eye could be seen after 23 hours was designated the MIC.
One hundred microliters of each culture which exhibited no visible
growth was plated out in triplicate and incubated at 37° C for 23 hours.
The concentration which allowed no growth on the plates was designated
the MBC.

RATE OF PROTEIN SYNTHESIS

A growing culture of bacteria in early log phase was treated with
antibiotic(s) (norfloxacin, nalidixic acid, and/or chloramphenicol).
The rate of DNA or protein synthesis was determined by a modification of
the method of Engle et tl· {19).

A flask containing 60 ml of Luria

broth was inoculated with f. aeruginosa to 9 Klett units (OD 660 ) and
incubated in a 37° C water bath with shaking until the culture grew to
20 Klett units (early log phase).

The culture was then split into three

flasks (20 ml each), one of which was treated with norfloxacin, another
with nalidixic acid, and tpe other with buffer containing no drug (100
microliters of .01 N NaOH).

At various times, 0.2 ml samples were
removed and protein labeled with L-[4,5- 3H]-leucine (1 microcurie/ml).

After 4 minutes, NaOH (final concentration 0.3 N) and EDTA (final
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concentration 0 .1%) was added.
micrograms/ml

of

bovine

serum

The protein was prec i pi ta ted with 40
albumin

(BSA)

trichloroacetic acid (final concentrations).

and

five

percent

The protein precipitates

were collected on nitrocellulose filters, and counted in a Beckman LS
7500 scintillation counter.

RATE OF DNA SYNTHESIS

The rate of DNA synthesis was measured in the same way that the
rate of protein synthesis was measured except that [ 3H]-adenine (1
microcurie/ml) was used and RNA was hydrolyzed by incubating the samples
at 37° C overnight.

KILLING EFFECTS OF ANTIBIOTICS

A growing culture of bacteria in early log phase was divided into
several aliquots and added to flasks containing various combinations of
antibiotics

(2700

micrograms/ml

nalidixic

acid,

norfl oxac in,

100

micrograms/ml

rifamycin,

and

chloramphenicol).

16

micrograms/ml

500

micrograms/ml

These were incubated with shaking at 37° C and the

number of colony forming units (CFU's) /ml counted.

WEIGLE REACTIVATION AND MUTAGENESIS
A concentration of 10 6 phage D3/ml was exposed to ultraviolet
radiation at 30 Joules/meter 2. A growing culture of bacteria in early
log phase was treated with antibiotic.

At various times 0.2 ml samples
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of bacteria were removed and exposed to UV-treated phage.

After 7

minutes at room temperature, A top agar was added and the mixture plated
out on Luria agar plates.

After incubating at 37° C overnight, the

number of plaque forming units were counted to determine Weigle
reactivation.

Also, to determine mutagenesis, the number of D3 wild

type plaques (cloudy phenotype) which reverted to the D3 mutant plaques
(clear phenotype) was counted.

PLASMID MAINTENANCE

PA0303 and RMB were made competent by MgCl 2 treatment ( 47) and
transformed with plasmid pME292 which carries resistance to
carbenicillin. A concentration of 106 plasmid-containing cells/ml were
exposed to varying concentrations of norfloxacin, nalidixic acid, or
novobiocin up to the MBC and incubated with shaking at 37° C. After 23
hours, bacteria were diluted and plated on Luria agar plates.

After

incubating at 37° C overnight, the plates were replica plated onto Luria
agar plates containing 500 micrograms/ml

of carbenicillin.

After

incubation at 37° C, the number of carbenicillin-resistant colonies was
counted to determine how many still contained the plasmid.

PURIFICATION OF DNA GYRASE

Three Luria agar

plat~s

(40 cm by 24 cm each) were inoculated with

P. aeruginosa strain PA0303 or
overnight at 37° C.

~·

coli strand H560 and incubated

Cells were harvested (wet weight 25 grams) and

suspended in 100 ml of 0.85% NaCl, incubated with shaking for 10 minutes

28

and centrifuged at 10,000 xg for

ten minutes.

The pellet was

resuspended at a concentration of 0.5 g/ml of a 10% sucrose solution
prepared in 50 mM Tris-HCl (pH 8.0). The suspension was frozen in a dry
ice-ethanol bath and thawed in a 25° C water bath.

The volume was

measured and 0.1 ml of a solution of lysozyme (2 mg/ml) was added for
each ml.

The mixture was allowed to incubate at o° C for 60 minutes.

All subsequent reactions were carried out at 4° C.
centrifuged for 30 minutes at 35,000 xg.

The solution was

The supernatant was decanted

(Fraction I) (56).
The magnesium acetate concentration of this crude extract was
adjusted to 5 mM and the extract was centrifuged for 4 hours at 30,000
rpm in a Beckman Ti50 rotor.

The supernatant (Fraction II) was loaded

onto a novobiocin-Sepharous (75) column and washed with buffer A (0.2 M
KCl, 5 mM dithiothreitol, and 10% glycerol) until the OD 280 of the
eluant reached a minimum. DNA gyrase was eluted from the column with 5
I

M urea in buffer A.

One ml fractions were collected and dialyzed

against buffer B (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, and 10% glycerol)
for 4 hours.

The fractions were then dialyzed for an additional 20

hours against buffer B in the presence of 5 mM dithiothreitol.

Each

fraction was tested for supercoil i ng activity and the active fractions
pooled.

PREPARATION OF RELAXED DNA

Col El DNA was isolated from -E. -coli strain JC 411 by growing a one
liter culture in Luria broth to 40 Klett units and amplifying the
plasmid by adding 200 micrograms/ml of chloramphenicol and incubating in

29

a 37° C water bath with shaking overnight.

The cells were then

harvested at 10,000 xg for 10 minutes, resuspended in saline and
incubated in a 37° C water bath with shaking for 15 minutes in order to
deplete the pools of ATP in the cells.

The cells were then harvested

again at 10,000 xg for 10 minutes and resuspended in 33 ml of cold 25%
sucrose in 50 mM Tris-HCl (pH 8.0) and 6.6 mls of solution containing 2
mg/ml of lysozyme in 0.25 M Tris-HCl (pH 8.0) was added.

After the

mixture was swirled gently for 5 minutes in a o° C ice bath, 14 ml of
cold .25 M ethylenediaminetetraacetic acid (EDTA, pH 8.0) was added.
After mixing at o° C for another 5 minutes, 40 ml of cold two percent
Sarkosyl in 0.05 M Tris-HCl (pH 8.0) and 0.0625 M EDTA was added.

Five

molar NaCl was added to a final concentration of one molar after another
five minutes of mixing at o° C.
four

hours

to

overnight.

Mixing was then continued at 4° C for

The

supernatant

was

collected

after

centrifugation at 17,000 xg for 30 minutes and DNA was precipitated at
20° C overnight after adding potassium acetate to a final concentration
of 0.3 Mand two volumes of 95% ethanol.
DNA was collected by centrifuging at 12 ,000 xg at o° C for 30
minutes, discarding the supernatant and drying the pellet.

The pellet

was dissolved in 16 mls of 10 mM Tris-HCl (pH 8.0) and 1 mM EDTA (TE)
after which 17 .6 grams of cesium chloride and 1.6 mls of 5 ml/ml
ethidium bromide was added.

This mixture, which was kept in the dark

from this point on in order to avoid nicking of the DNA, was centrifuged
in a VTI65 rotor at 40.000 xg for 16 hours in a Beckman L5-50
ultracentrifuge.

Under ultraviolet (UV) light, the plasmid band could

be visualized below the chromosomal band.

The plasmid band was isolated

by inserting a 38.1 mm hypodermic needle just under the band and one at
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the top of the tube.

The liquid which flowed out of the tube was

collected until the band almost disappeared and the chromosomal band was
nearing the needle.

Ethidium bromide was extracted three times with

isopropanol saturated in a solution of cesium chloride.

Potassium

acetate was added to a concentration of 0.3 M and then four volumes of
ethanol was added. After keeping at -20° C overnight, DNA was collected
by centrifuging at 12,000 xg for 15 minutes at

o° C, discarding the

supernatant, drying the pellet and resuspending in TE.
examined

and

the

concentration

determined

by

The DNA was

electrophoresis

of

differing amounts of the DNA on a 0.8% agarous gel gel at 50 volts for
17 hours with appropriate size and concentration controls.

The DNA was

visualized by staining the gel in 1 mg/ml ethidium bromide and placing
on a UV light box.
Supercoiled phage

~X174

(Amersham) or Col El DNA was relaxed with

topoisomerase I (Amersham). Twenty-five micrograms of DNA and 1.7 units
of topoisomerase I were incubated at 37° C overnight in a 25 microliter
volume containing 10 mM Tris-HCl (pH 7.8), 100 mM NaCl, 1 mM EDTA, and
0.1 mg/ml of bovine serum albumin (BSA).

Topoisomerase was inactivated

by incubating at 70° C for 10 minutes and extracted with chloroform and
isopropanol

at a ratio of 24:1.

The

product was

examined

by

electrophoresis as described above.
Amersham observed no nuclease activity in the topoisomerase I after
incubation of 1 microgram of pBR type 1 DNA with 40 units of enzyme for
30 minutes at 370 C in th~ relaxation buffer described above containing
1-10 mM MgC1 •

2
Relaxed DNA was also prepared with a nicking-closing extract which

was prepared from chicken red blood cells as described by Comerini-Otero
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and Felsenfeld (8).

Red blood cells were harvested from whole chicken

blood by centrifuging at 10,000 xg for 10 minutes.

The pellet was

washed four times with phosphate buffered saline (PBS buffer) by
centrifugation and resuspension.

The cells were then resuspended in

0.25 M sucrose, 10 mM Tris-HCl (pH 8.0), and 1 mM magnesium acetate and
washed twice.

The cells were washed five times in the same sucrose

solution and 0.5% (v/v) Triton X-100.

The resulting nuclei were then

washed an additional three times in the absence of Triton.

The nuclei

were swollen by washing them in 10 mM Tris-HCl (pH 8.0), 0.5 mM EDTA.
In all

cases, a Dounce homogenizer (loose pestle) was used for
The nuclei, swollen to about five to ten times their

resuspension.

original volume, were then mixed with an equal volume of 300 mM
phosphate buffer (pH 7.5), homogenized with a Dounce homogenizer, and
centrifuged at 25,000 xg for 15 minutes.
nicking-closing

extract,

was

monitored

The supernatant, which is the
for

relaxing

activity

by

measuring the conversion of supercoiled Col El DNA to the relaxed
closed-circular form as demonstrated by agarose gel electrophoresis
(described above).
The nicking-closing extract was used to prepare relaxed DNA
substrate in a 50 microliter reaction volume which contained 42
microliters of nicking-closing extract and 30 micrograms of supercoiled
Col El DNA or

~Xl74

DNA in 100 mM NaCl, 10 mM Tris-HCl (pH 7.8), 0.25 mM

EDTA, and 2.5% (v/v) glycerol.
for 30 minutes.

The reaction was carried out at 37° C

Enzyme was inactivated by heating at 70° C for 10

minutes followed by extraction in chloroform:isopropanol at a ratio of
24:1.

The product was examined by agarose gel electrophoresis as

described above.
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SUPERCOILING REACTION
I determined the units of activity of my preparations of DNA gyrase
as the amount of enzyme required to completely supercoil 0.5 micrograms
of relaxed DNA at 37° C in 30 minutes in a 25 microliter reaction volume
containing 50 mM Tris-HCl (pH 7.6), 20 mM KCl, 10 mM MgC1 2, 2 mM
dithiothreitol, 1.5 mM ATP, 5 mM spermidine-Cl 3 , and 50 micrograms/ml
BSA.

If the units were determined using relaxed Col El DNA, then this

same DNA was used for all subsequent experiments.
for when relaxed

~X174

The same holds true

DNA was used.

Three other buffers were also used in order to perfect the
supercoiling conditions, however, they were not used in any of the final
experiments.

The other buffers were:

buffer 1 (35 mM Tris-HCl (pH

7.5), 6 mM MgC1 2, 1.5 mM DTT, 1.5 mM spermidine-HCl, 1.5 mM ATP, and 50
micrograms/ml of BSA), buffer 2 (35 mM Tris-HCl (pH 7.5), 1.6 mM MgC1 2,
19 mM KP0 4 (pH 7.5), 5 mM spermidine-HCl, 1.4 mM ATP, 90 micrograms/ml
~·

coli tRNA, and 3.6 mg/ml BSA), and buffer 3 (35 mM Tris-HCl (pH 7.5),

20 mM MgCl 2, 20 mM KCl, 0.1 mM EDTA, 10 mM 2-mercaptoethanol, 2 mM
spermidine-HCl, 1 mM ATP, 40 micrograms/ml BSA, and 10% (w/v) glycerol).
To stop the reaction, a mixture of 20% Ficoll and 400 micrograms/ml
of bromopheno l blue was added.

The total volume of the samples was

loaded onto a 0.8% agarous gel and electrophoresed at 50 volts for at
least 14 hours in TBE (89 mM Tris base, 89 mM boric acid, 2.5 mM EDTA).
The gels were stained with ethidium bromide (0.5 micrograms/ml) for 15
!

minutes and destained in water for 15 minutes before being photographed
under ultraviolet

light.

DNA's

supercoiled

to different extents

migrated as individual bands with the most greatly supercoiled DNA
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migrating farthest (lowest band), the completely relaxed DNA migrating
the least (highest band), and with the linear DNA migrating as a band in
between the completely relaxed and completely supercoiled DNA.

RELAXATION REACTION

One unit of the DNA gyrase preparation was incubated with 0.5
micrograms of supercoiled ~X174 DNA at 37° C for 2 hours in a 25
microliter volume containing 35 mM Tris-HCl (pH 7.5), 6 mM MgC1 2 , 18 mM
potassium phosphate, 1.8 nt>1 spermidine-Cl 3 , 9 micrograms/ml ~· coli
tRNA, 0.36 mg/ml BSA, and 5 mM dithiothreitol.

The reaction was

stopped, electrophoresed, and photographed the same as the supercoiled
reaction.
The velocity of the relaxation reaction in the presence and absence
of drug was measured by taking densitometric tracings of negatives of
gels.

As the DNA is relaxed, a ladder of bands between the competely

supercoiled DNA and completely relaxed DNA bands is observed on the gel.
As the A subunit decreases the superhelical density by two, the DNA
molecule will migrate one band up.

Each band of DNA was assigned an

even number depending on where it migrated on the gel.

The fastest

migrating band was assigned zero and the bands above this were given
even numbers from two up.

The to ta 1 decrease in superhe 1ica1 density

was determined by multiplying the percentage of DNA in each band as
determined by densitometriF tracings of the negatives of pictures of the
gels by its assigned number and adding up the products.
The velocity was derived by plotting the total

decrease in

superhelical density against the time that the reaction was allowed to
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continue.

The slope of the line is equal to the velocity.

Linear

regression was performed on all the data using a Texas Instruments Tl55
calculator in order to determine the slope of the line.

Table 4 shows

one example of the data used to calculate the velocity for various
substrate concentrations.

Since each experiment did not always result

in the same number of topoisomer bands, the velocities in the presence
of different antibiotics cannot be directly compared and the maximal
velocity determined from these velocity units would be arbitrary.
The Michaelis constant (Km) of the relaxation reaction was derived
by a Hanes plot (27), the equation of which is:
s/v

= ~/V

+ s/V

1.

where s is the substrate (supercoiled DNA) concentration, v is the
velocity, and V is the maximal velocity.

This shows that a plot of s/v

against s should be a straight line with slope 1/v and X-intercept -Km.
The Hanes plot is preferred over the other straight line plots because
multiplying 1/v by s lessens the large errors that result from taking
the reciprocal of small v values that have even slight errors in them.
The inhibition constants (Ki's) of the different pyridonecarboxylic
acid derivatives were derived by a Dixon plot (12), the equation for
which is:
1 -

-v-

Km ts
Vs

+

CKm/Kj + s/K·'li
Vs

'

where i is the inhibitor (pyridonecarboxylic acid) concentration.

This

shows that a plot of 1/v against i at a constant value of s is a
straight line.

When two

or

more such lines are drawn for two or more

different s values, the point of intersection along the y axis is equal
to -Ki.
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Table 4.

Substrate
Concen~ration

(x 10mMoles/ml)

Calculation of the Velocity of the Relaxation Reaction.

Time
(min)

Decrease in
Superhel ical
Density

Slope

Correlation
Coefficient

0.85

30
60
12{)

62.34
69.63
73.99

0 .122095

0.944

1. 7

30
60
120

75.54
77 .49
87.25

0.1347619

0.984

3.4

60
120
180

76.12
81.94
94.40

0.1531917

0.980

6.9

30
60

68.63
75.56

0.231

1.0

"'
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An exactly similar derivation to the Dixon plot by Cornish-Bowden
(9) shows that by plotting s/v against i at several s values, a set of
straight lines that intersect at -K. is again obtained.
1

However, in

this case, if the lines are parallel the inhibition is competitive.

CLEAVAGE REACTION

One unit of the DNA gyrase preparation was incubated with

~X174

DNA

under the same reaction conditions which were used to determine the
units

of

supercoiling

activity

except

that

one

mg/ml

of

pyridonecarboxylic acid and, in some cases, 1.5 mM ATP or 1.5 mM
adenylyl-imidodiphosphate (AppNp) was added.

After 30 minutes, 11 mM

EDTA, 2 mg/ml SDS, and in one case 90 micrograms/ml of proteinase K was
added.

The incubation was continued for 60 minutes.

The reaction was

electrophoresed and photographed the same as the supercoiling reaction.

CATENATION REACTION

This reaction was not specifically tested for, but was observed
when the supercoiling reaction products were examined.

On the gels that

contained the supercoiling reactions products, bands that migrated much
higher than the relaxed DNA band appeared.

In some cases, the reaction

was extracted with a 24:1 mixture of chloroform and isopropanol before
loading, the gel.
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ATPase REACTION

ATPase activity was measured in the supercoiling reaction mixture
(described in the Supercoiling Reaction section) after the 30 minute
incubation by measuring the release of inorganic phosphate as described
by Lanzetta et

~·

(46).

Two control reactions carried out in the

absence of DNA gyrase or ATP were also measured for release of inorganic
phosphate.
The following stock solutions were prepared with distilled water in
glassware that was well rinsed in order to remove any detergents that
may have been left over from the dishwashing process:

0.045% malachite

green hydrochloride (MG}, 4.2% ammonium molybdate in 4 N HCl (AM), 34%
sodium citrate-2H 2o (w/v), and 10 mM KH 2Po 4 (salt was dried several
hours at 100° C}; appropriate dilutions were made from this stock and
used for standards.

The color reagent was prepared from the above

solutions as follows:

a 3:1 mixture of MG and AM solutions was mixed at

least 20 minutes and then passed through Whatman No. 5 filter paper
(MG/AM),

and

100

microliters

of

Sterox

(purchased

from

Instruments) was added to 5 ml of MG/AM solution (MG/AM/St).

Coleman
To 25

microliters of sample or standard, 400 microliters of the MG/AM/St
solution was added mixed.

After one minute, 100 microliters of the

citrate solution was added and mixed.

of this solution was
660
read after allowing it to sit at room temperature for 2 hours. A

standard calibration

curv~.

The 00

was prepared from the standards previously

described every time the experiment was performed.

The 00

of the
660
supercoiling reactions was compared to this standard curve in order to
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determine the amount of inorganic phosphate released (the amount of ATP
hydrolyzed) as compared to the controls.

EFFECTS OF ANTIBIOTICS

The reactions of DNA gyrase were carried out as described above in
the

presence

of

norfloxacin,

nalidixic

acid,

oxolinic

novobiocin at concentrations ranging from the MIC to one mg/ml.

acid,

or

RESULTS

POTENCY OF PYRIDONECARBOXYLIC ACID DERIVATIVES ON P. AERUGINOSA

The potency of norfloxacin and nalidixic acid as bacteriostatic and
bactericidal agents for the strains to be used in this study was
determined by measuring the MIC and MBC of both drugs (Table 5).

These

concentrations were consistent with those determined for other strains
of f. aeruginosa (30).

Norfloxacin was several hundred to a thousand

fold more potent than nalidixic acid for all strains tested.

Strains

deficient in recombination (Rec-) were studied because Rec- E. coli
strains were found to be unable to recover from inhibition of DNA
synthesis (19).

Our Rec- strain RMB was slightly more resistant than

its parent, strain PA0303, to both norfloxacin and nalidixic acid.
Another Rec- strain, PA02002 was slightly less resistant to nalidixic
acid and exhibited the same level of tolerance to norfloxacin.

Since

the exact reasons for the Rec- phenotypes of these strains is unknown,
speculation

as

to

why

the

mutations

cause

differences

in

pyridonecarboxylic acid resistance is left for a later date.

However,

it does

in

appear

that

recombination

is

somehow

involved

drug

resistance.
Spontaneous mutants, of PA0303 resistant to norfloxacin (RM166,
RM167, and RM169) were isolated as described in Materials and Methods
and found to also be resistant to nalidixic acid.

RM4000, a spontaneous

mutant of RMB resistant to nalidixic acid which happened to be available
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Table 5.

The MIC's and MBC's for Norfloxacin and Nalidixic Acid
in f. aeruginosa Strains

Strain

Nalidixic Acid
MIC
MBC
(micrograms/ml)

PA0303

350

2000a

0.4

16.0

RM166 (Norr)

2000

3000b

6

20.0

RM167 (Norr)

2700

3000b

9

20.0

RM168 (Norr)

3000

3000b

8

20.0

RM169 (Norr)

2500

3000b

6

15.0

700

2000a

1.6

16.0

3000

3000b

6a

20a

175

700a

1.6

2.5a

44

700a

1.6

2.5a

RMB (Rec-)
RM4000 (Nalr)
PA02001
PA02002 (Rec-)

~This is an approximate value.

Norfloxacin
MBC
MIC
(micrograms/ml)

This is a minimum value due to the insolubility of nalidixic acid at
concentrations above 3000 micrograms/ml.

"'
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in our lab, was found to also be resistant to norfloxacin.

This

indicates that the two drugs act similarly in that they have the same
mechanism of transport into the cells, they have the same targets of
action, or both.
The optical density of a culture of cells is a measure of the
number of cells in that culture.
culture of
4).

E·

The optical density of a growing

aeruginosa cells increases exponentially over time (Figure

When a culture in exponential (log) growth phase was treated with

norfloxacin at a concentration equal to the MIC (0.4 micrograms/ml) or
four times the MIC (1.6 micrograms/ml), the rate of growth decreased for
about 100 minutes after which there was no more growth.

When a

concentration equal to the M8C (16 micrograms/ml} was used, there was an
immediate inhibition of growth.

A culture in late log phase, however,

exhibited no significant decrease in the growth rate when treated with
the M8C of norfloxacin (Figure 5).
When PA0303 was exposed to nalidixic acid or norfloxacin at a
concentration equal to the M8C for these drugs (16 micrograms/ml and
2800

micrograms/ml},

recovered

was

the

number

drastically

of

reduced

colony-forming
(Figures

6A

units

and

(CFU's)

7A).

When

chloramphenicol or rifamycin was also present in the culture medium, it
eliminated the bactericidal effects of norfloxacin and nal idixic acid.
Any reduction in CFU's/ml could be attributed to the bacteriostatic
effect of chloramphenicol or rifamycin alone.
were

repeated

with

the~,

chloramphenicol

did

not

Rec

strain

alleviate

norfloxacin or nalidixic acid.

RMB
the

When these experiments
(Figures

bactericidal

68

and
effects

78),
of
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Figure 4.

Inhibition of Mid-Log Phase Growth by Norfloxacin.

The growth of a culture o.f PA0303 was followed by measuring the Klett
(0066) at various times. At 150 minutes, the culture was divided into
four portions. Each portion was treated with buffer containing norfloxacin at the MBC (Q), four times the MIC (0), the MIC (*),or buffer
containing no drug(~).
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3~0

400

The Effect of Norfloxacin on Late-Log Phase Growth.

The growth of a culture of PA0303 was fo 11 owed by measuring the Klett
(00660) at various times. At 200 minutes, the culture was divided.
Half was treated with the.MSC of norfloxacin (O) and half was treated
with buffer containing no drug(~).
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Time (hr)

Figure 6.

The Bactericidal Effect of Pyridonecarboxylic Acid and
Chloramphenicol.

Logarithmically grow.ing cultures of PA0303 ()\)\and RMS (B) were divi.d~d.
Portions were treated with norfloxacin (~J, nalidixic acid (~),
chloramphenicol (.), nor:floxacin and chloramphenicol ( }, nalidixic
acid and chloramphehicol .(.), or buffer without added drug (e) as
described in the text. At various times, samples were taken and the
CFU/ml of the culture determined.
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The Bactericidal Effect of Pyridonecarboxylic Acids and
Rifamycin.

Logarithmically growing cultures of PA0303 (A) and RMB (B) were divided.
Portions were treated with norfloxacin (~), nalidixic acid (()},
rifamycin (0), rifamycin· and norfloxacin (-*), rifamycin and nalidixic
acid (()},or buffer without added drug(~) as described in the Methods
section. At various times, samples were taken and the CFU/ml of the
culture determined.
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FI LAMENTATION

Filamentation was not seen when PA0303 was treated with nalidixic
acid or norfloxacin (Figure BA and C, respectively}.

Cell division

events were observed even after 23 hours of treatment when the number of
CFU's/ml indicate that the cells are no longer viable (Figures 6 and 7,
BA and BC).

Simultaneous treatment with both chloramphenicol and

pyridonecarboxyl ic acid did not stop the cell division events from
taking place (Figure BE).
Many of the Rec- strain (RMB) cells treated with nal idixic acid
filamented (Figure BB}, while only very few of the cells treated with
norfloxacin showed even a slight increase in size (Figure BD). Some of
the cells treated simultaneously with nalidixic acid and chloramphenicol
filamented also (Figure BF).

In all cases, cell division events were

observed.

RATE OF PROTEIN SYNTHESIS

The rate of protein synthesis in an exponentially growing culture
of

f.

aeruginosa increases logarithmically with time (Figure 9).

Nalidixic acid inhibited protein synthesis about 99 percent, while
norfloxacin inhibited protein synthesis only about 50 percent.

~ATE

OF DNA SYNTHESIS

The rate of DNA synthesis in a growing culture of f. aeruginosa
cells (PA0303) was inhibited by norfloxacin (Figure 10). Increasing the

47

Figure 8.

Lethal Unbalanced Growth in Pyridonecarboxylic Acid Treated
Cells.

The cultures described in Figure 5 were photographed at a magnification
of xl800 after 24 hours of incubation. Strain PA0303 (A, C, E, and G)
or RMB (B, D, F, and H) were treated with norfloxacin (C and D}, nalidixic acid (A and B), nal idixic acid and chloramphenicol (E and F) or
buffer containing no drugs (G and H). Arrows point out cells that
appear to have just completed cell division.
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Figure 9.

Inhibition of Protein Synthesis by Pyridonecarboxylic Acids.

Logarithmically growing cultures of RMS were divided, and portions were
treated with four times the MIC of norfloxacin (~.), four times the MIC
of nalidixic acid(*), or buffer containing no drug (e). At various
times, samples were taken and the rate of protein synthesis measured as
described in the text.
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Figure 10.

Inhibition of the Rate of DNA Synthesis as a Function of
Norfloxacin Concentration.

Logarithmically growing cultures of strain PA0303 ( O), RMB (0), or
RM168 (A) were divided and exposed to various concentrations of norfloxacin. The rate of DNA synthesis was measured after four minutes of
exposure as described in the text.
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concentration of norfloxacin resulted in an increase in the amount of
inhibition

up

micrograms/ml).

to

a

plateau

that

occurred

around

the

MBC

(16

RMB (the Rec- mutant) and RM16B (the spontaneous mutant

resistant to norfloxacin) were inhibited to a lesser extent than their
parent PA0303

(Rec+,

Nors).

In order to keep these experiments

consistent with similar experiments performed on E. coli (20), a drug
concentration of four times the MIC was used.
The rate of DNA syn thesis of a culture of P. aerugi nos a in log
phase increased exponentially over time (Figure 11).

Treatment of

PA0303 (Rec+) with either norfloxacin or nalidixic acid (Figure llA and
12, respectively) at a concentration of four times the MIC caused an
immediate inhibition of DNA synthesis followed by recovery synthesis
that was also exponential and that occurred within 5 minutes of drug
treatment.

No recovery synthesis was observed at concentrations equal

to the MBC of norfloxacin (Figure llA).
simultaneously with

norfloxacin

Inhibition of protein synthesis

treatment did

not allow recovery

synthesis (Figure 13A).
When RMB was treated with nalidixic acid at a concentration of four
times the MIC (Figure 128), recovery synthesis occurred but could not be
sustained, whereas it could be sustained if norfloxacin was used (Figure
llB).
recovery

Concentrations as high as the MBC for norfloxacin allowed
synthesis

that

could

be

sustained

(Figure

118).

This

difference observed between nalidixic acid and norfloxacin in the Recmutant may be because na1Jidixic acid inhibits protein synthesis 99%,
while norfloxacin inhibits protein synthesis only 50%.
synthesis was

inhibited simultaneously with

norfloxacin

If protein
treatment

(Figure 13A), the recovery synthesis could no longer be sustained in the
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Figure 11. The Effects of Norfloxacin on the Rate of DNA Synthesis in
PA0303 and RMB Cultures.
Logarithmically growing cultures of PA0303 (A), RMB
were divided and portions ,were exposed to four times
acin (0), the MBC or norfloxacin (0), or buffer
( •.). At various times, samples were taken and the
sis measured as described in the text.
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the MIC of norfl oxcontaining no drug
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Figure 12. The Effects of Nalidixic Acid on the Rate of DNA Synthesis
in PA0303 and RMB Cultures.
Logarithmically growing cultures of PA0303 (A) and RMB (B) were divided,
half was treated with four times the MIC of nalidixic acid (0), and
half was treated with buffer containing no drug (~). At various times,
samples were taken and the rate of DNA synthesis measured as·described
in the text.
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Figure 13. The Effects of Simultaneous Treatment with Norfloxacin and
Chloramphenicol on the Rate of DNA Synthesis in PA0303 and
RMB Cultures.
Logarithmically growing cuJtures of PA0303 (A) and RMB (B) were divided
and portions were exposed to chloramphenicol ([]), chloramphenicol and
norfloxacin (()), or buffer without added drugs (~). At various times
after introduction of the drug(s), samples were taken, and the rate of
DNA synthesis measured as described in the text.
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Rec- mutant.

Inhibition of protein synthesis simultaneously with

nalidixic acid treatment had no effect on the recovery synthesis in
either the Rec+ or Rec- strains.
The rate of DNA synthesis of another Rec- mutant (PA02002) and its
parent (PA02001) were measured (Figure 14).

These strains have a very

long generation time of 75 minutes as compared to the generation time of
30 minutes for strain PA0303, accordingly, their rate of DNA synthesis
is much slower than strain PA0303.

Norfloxacin or nalidixic acid

treatment caused an immediate inhibition of DNA synthesis followed by
recovery synthesis in the parent (Figure 14A and C) or by a slower rate
of inhibition in the Rec- mutant (Figure 148 and D).

Since the slopes

of these lines were so small, linear regression was performed on these
lines to determine if their slopes were indeed positive in the case of
strain PA02000 and negative in the case of strain PA02001. These slopes
are given in the figure legend.
RM168, a spontaneous mutant of PA0303, resistant to norfloxacin,
was inhibited to a lesser extent than its parent (Figure 10).

However,

its inhibition and recovery of DNA synthesis occurred within the same
time frame as the wild type's (Figure llC).
RM4000, a spontaneous mutant of RMB, resistant to nalidixic acid,
exhibited no recovery synthesis when treated with norfloxacin or
nalidixic acid (Figures 15A and B, respectively).

INDUCTION OF DNA REPAIR PATHWAYS

Inducible DNA repair systems in a bacterium can be studied by
treating cells with an inducing agent such as ultraviolet radiation or
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Figure 14. The Effects of Norfloxacin and Nalidixic Acid on the Rate of
DNA Synthesis in PA02001 and PA02002 Cultures.
Logarithmically growing cultures of PA02001 (A and C) and PA02002 (B and
D) were divided, half wa$ treated with norfloxacin (A and B) or nalidixic acid (C and D) at a concentration of four times the MIC (()) and
half was treated with buffer containing no added drug (e). At various
times, samples were taken and the rate of DNA syn thesis measured as
described in the text. The slopes of the lower lines are +0.376 for A,
-0.16 for B, +0.111 for C, and -0.029 for D.
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The Effects of Norfloxacin and Nalidixic Acid on the Rate of DNA Synthesis in Strain
RM4000.

Logarithmically growing cultures of RM4000 were divided, half was treated with norfloxacin (A) or
nalidixic acid (B) at a concentration of four times the MIC (O), and half was treated with buffer
containing no added drug ( •). At various times, samples were taken and the rate of DNA synthesis
measured as described in the text.
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nalidixic acid and subsequently infecting the treated cells with
UV-damaged phage DNA.

The cells are plated out and the number of plaque

forming units (PFU's) counted.

If a DNA repair system has been induced

by the agent, then the number of PFU's in the treated culture will be
exponentially greater than the number of PFU's in the control culture.
This phenomenon, termed Weigle reactivation, is observed in E. coli
cells treated with nalidixic acid (69).
Mutagenesis can be measured during the same experiment.

The

Pseudomonas phage D3 has a high frequency of mutation to the clear
plaque phenotype as opposed to the wild type cloudy plaque.

If a DNA

damaging treatment is inducing an error-prone repair system, then the
percentage of clear plaques in the treated culture will be greater than
the percentage of clear plaques in the control culture.
Neither Weigle reactivation (Figure 16) nor mutagenesis (Table 6)
was observed when PA0303 (Rec+) or RMB (Rec-) cells were treated with
norfloxacin or nalidixic acid.

This is not surprising, since treatment

with ultraviolet light does not induce these pathways in the Rec+ or
Rec- strains of P. aeruginosa (66).

PLASMID MAINTENANCE

Treatment of

~·

coli strains containing plasmid pBR322 or plasmid

pMGllO with coumermycin Al, an inhibitor of the DNA gyrase B subunit,
results in loss of

thes~,

plasmids from the cells (B5).

The plasmid

pME292 was transformed into PA0303 and RMB made competent by MgCl 2
treatment (53). Treatment with varying concentrations of norfloxacin,
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Figure 16. The Absence of Weigle Reactivation in Strains PA0303 and
RMB.
.
At time zero, a culture of PA0303 (A and C) and RMB (B and D) was
treated with either norfloxacin (A and B) or nalidixic acid (C and D) at
a concentration of four times the MIC. At various times, samples were
taken, and infected with UV-irradiated (30 J/m2) phage 03. The titer of
phage (PFU/ml) relative to the titer at time zero was determined.
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Table 6.

Drug

Norfloxacin

Nalidixic

Frequency of Mutagenesis in the Presence of
Norfloxacin or Nalidixic Acid.

Time of Exposure
(min)

Mutation Fr~quency
(mutants/10 PFU)

0

10

5

11

30

11

50

8

0

17

5

9

30

11

50

6
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nalidixic acid, or novobiocin up to the MBC's did not cause any loss of
plasmid from either strain (Table 7).

PSEUDOMONAS AERUGINOSA DNA GYRASE

DNA

gyrase

was

isolated

from

strain

PA0303

by

affinity

chromatography (Table 8) on a novobiocin-Sepharous column {75) and found
to consist of two subunits whose molecular weights were determined to be
92,000

~

3,000

electrophoresis.

and

108,000

~

3,000

by

SOS

polyacrylamide

gel

Depending on the preparation, either two or four bands

were observed on the SOS gel of the final purified fraction.

The 92,000

and 108,000 bands, which are presumably the two subunits of DNA gyrase,
appeared consistently.

Two other less intense bands of molecular

weights 40,000 and 50,000 were sometimes observed.

Unfortunately, with

the equipment available and with my lack of expertise in the area of
photography, I was unable to obtain a photograph that could distinguish
these bands very well (Figure 17).
The two smaller, less intense bands may consist of proteins which
bind to novobiocin since the preparation eluted off of a well washed
novobiocin-Sepharous affinity column.

Staudenbauer and Orr (75) also

observed two smaller additional proteins other than the DNA gyrase
subunits eluting off of the novobiocin-Sepharous affinity column loaded
with an E. coli extract.

One of these additional proteins, which has a

has an unknown function.
molecular weight of 85,00.0,
,.

They speculate

that the other protein of molecular weight 40,000 may be generated from
the same proteolytic cleavage event that generates the v subunit of
molecular weight 50,000. The two smaller, less intense bands which I

61

Table 7.
Drug

Norfloxacin

Nalidixic Acid

Novobiocin

Plasmid Maintenance

Concentration
(micrograms/ml)

Plasmid Maintenance
{percent)

0

99.9

0.2

99.9

0.4

99.9

1.6

99.9

0

99.9

350

99.9

700

99.9

0

99.9

1

99.9

The data is exactly the same for strains PA0303 and RMB.
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Table 8.

Purification of P. aeruginosa DNA Gyrase.

Total
Enzyme
Activity

Specific
Activity
units/mg

4.896

*

*

20

4.096

*

*

5

0.29

2000

34,483

Total
Volume
(ml)

Total
Protein
(mg)

I

22.5

II

Fraction

II I

*No enzyme activity could be determined in these fractions.
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Figure 17.

SOS Polyacrylamide Gel of Purified

f. aeruginosa DNA Gyrase.

Purified P. aeruginosa DNA gyrase (lane 1) and SDS-PAGE high molecular
weight standards llane 2) were electrophoresed in 10% SOS polyacrylamide
tube gels.
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observed, also might consist of proteolytic products of the B subunit
and maybe even the A subunit. The proteolysis may have occurred before,
during or after the purification procedure.

The B subunit may also

autoproteolyze, a phenomenon which is also observed for the
protein (46).

1·

coli lexA

This autoproteolysis is suspected of my purified f.

aerugi nos a DNA gyrase because of the disappearance of the supercoil i ng
activity with time or freezing, as will be described in the next
section.

,SUPERCOILING OF RELAXED CLOSED CIRCULAR DNA
The supercoi 1i ng of re 1axed DNA by my purified f. aerugi nos a DNA
gyrase exhibited many irregularities.
with

the substrate

(relaxed Col

First of all, there were problems
El

or

~Xl74

DNA).

After many

unsuccessful attempts at increasing the superhe 1ica1 density of the
substrate with my purified f. aeruginosa DNA gyrase, I sent a sample of
my substrate to Dr. Martin Gellert. His purified
also unable to supercoil my substrate.

1·

coli DNA gyrase was

In order to relax supercoiled

DNA for substrate, I had been using a chicken nicking-closing extract
which was available in our lab and was about three or four years old.

I

therefore prepared fresh nicking-closing extract, which I used to relax
supercoiled

DNA.

This

also

led

to

relaxed

DNA

that

was

not

supercoilable (Figure 18).

I then attempted to improve the reaction

ou~

the reaction in different buffers (described

conditions by carrying

in the Methods section), none of which improved the results.
DNA purified using the exact same procedure as used for

f.

E. co 1i

aeruginosa

DNA gyrase was also unable to supercoil the substrate prepared with
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1 2 3 4

Figure 18.

8 9 10 11 12 13 14

Lack of Supercoiling Activity off. aeru~inosa and~· coli
DNA Gyrase on Nicking-Closing Extract-Re axed DNA.

Col El DNA relaxed with nicking-closing extract was incubated with f.
aeruginosa DNA gyrase (lanes 9-13) or~· coli DNA gyrase (lanes 2-8) as
described in the Methods section. Ea~ane contains a different
fraction collected from the novobiocin-Sepharose column. Lane 1 contains relaxed DNA incubated in the absence of DNA gyrase, and lane 14
contains supercoiled DNA.
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fresh

nicking-closing

extract

(Figure

topoisomerase I as a relaxing agent.

18).

Finally,

I

utilized

This resulted in relaxed DNA that

was supercoilable (Figures 19 and 21).
I only attained supercoiling on a fresh preparation of DNA gyrase
that was less than 24 hours off of the column and that had never been
frozen (Figure 19).

After the preparation was one day old or had been

frozen, I attained cut linear DNA.

Figure 19 shows the agarose gel of

the reaction products obtained when relaxed Col El DNA was used with a
fresh preparation of DNA gyrase, and Figure 20 shows the reaction
products from the same preparation that had been frozen.

It appears

that the circular Col El DNA treated with the older preparations
obtained a double-stranded cut resulting in linear DNA.

Figures 21 and

22 exhibit the reaction products obtained when relaxed 0Xl74 DNA was
used with a fresh or frozen preparation, respectively.
the circular

~Xl74

It appears that

DNA treated with the older preparation obtained two

double-stranded cuts resulting in two linear bands which migrate to the
same location as the linear DNA of the cleavage reaction (see Cleavage
Reaction

section).

The double-stranded cleavage may

result from

proteolytic products of the B subunit that are similar to the
subunit.

f.

Since the v subunit is a natural protein found in

aeruginosa possesses a DNA gyrase very similar to the

it is not unlikely that
to the

I·

f.

I·

I·

I·

coli v

coli and

coli enzyme,

aeruginosa also possesses a v subunit similar

coli v subunit. The loss of the supercoiling activity and the

gain of cleavage activityrmay be due to the v subunit being more stable
than the B subunit.
When I used relaxed Col El DNA, bands of topoisomers that were
increased in superhelical density occurred, but a completely supercoiled

67

1 2

Figure 19.

Supercoiling of Topoisomerase I-Relaxed Col El DNA by Fresh
aeruginosa DNA Gyrase Preparation.

£.

Col El DNA, which was relaxed with topoisomerase I, was incubated with
aeruginosa DNA gyrase (lanes 2-9) as described in the Methods
section. Each lane contains a different fraction collected from the
novobiocin-Sepharose column. Lane 1 contains relaxed DNA incubated in
the absence of DNA gyrase~ and lane 10 contains supercoiled DNA.

£.
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34 5 6 7 8 9101112

Figure 20.

Effects of Frozen £. aeruginosa DNA Gyrase Preparation on
Topoisomerase I-Relaxed Col El DNA.

Col El DNA, which was incompletely relaxed with topoisomerase I, was
incubated with £. aeruginosa DNA gyrase preparations which had been
stored frozen as described in the Methods section (lanes 2-8 and 10-11).
Each lane contains a different fraction collected from the novobiocinSepharose affinity column. Lane 1 contains incompletely relaxed DNA
incubated in the absence of DNA gyrase, lane 9 contains no DNA, and lane
12 contains supercoiled DNA.
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1 234 56 7891011121314

Figure 21.

Supercoiling of Topoisomerase I-Relaxed 0X174 DNA by Fresh
Preparations off. aeruginosa DNA Gyrase.

Topoisomerase I-relaxed 0X174 DNA was incubated with a fresh preparation
of DNA gyrase as described in the Methods section. Each lane contains a
different amount of preparation (12 µl in lane 2, 11 µl in lane 3, 10 µl
in lane 4, 9 µl in lane 5, 8 µl in lane 6, 7 µl in lane 7, 6 µl in lane
8, 5 µl in lane 9, 4 µl ir:i lane 10, 3 µl in lane 11, 2 µl in lane 12,
and 1 µl in lane 13 - for a 25 µl total reaction volume). Lane 1
contains relaxed DNA incubated in the absence of DNA gyrase and lane 14
contains supercoiled DNA.
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Figure 22.

Effect of Frozen ~· aeruginosa DNA Gyrase Preparations on
Topoisomerase I-Relaxed 0Xl74 DNA.

Topoisomerase I-relaxed 0Xl74 DNA was incubated with preparations of DNA
gyrase which were stored frozen for 24 hrs as described in the Methods
section. Of the 25 µl reaction volume, DNA gyrase preparation represented 11 µl in lane 1, 10 µl in lane 2, 9 µl in lane 3, 8 µl in lane 4,
7 µl in lane 5, 6 µl in lane 6, 5 µl in lane 7, 4 µl in lane 8, 3 µl in
lane 9, 2 µl in lane 10, 1 µl in lane 11, 1/2 µl in lane 12, 1/10 µl in
lane 13, and 0 µl in lane 16. Lanes 14 and 15 contain 11 µl of DNA
gyrase preparation which were stored frozen for a week and longer. Lane
17 contains supercoiled DNA.
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product was

never observed.

When

I used

~X174

DNA,

completely

supercoiled DNA appeared but no intermediate topoisomers were ever
observed (Figure 21).
when supercoiled

Intermediate topoisomers were observed, however,

~X174

DNA was relaxed with new or old DNA gyrase

preparations (see next section).
Inhibition of supercoiling by pyridonecarboxylic acids was not
observed.

An

unexpected

phenomenon did occur with topoisomerase

I-relaxed Col El DNA (Figure 23); supercoiling was not observed in the
absence or at low concentrations of pyridonecarboxylic acids, but
intermediate topoisomer bands appeared in reactions carried out in the
presence on MBC concentrations of norfl oxaci n ( 16 micrograms/ml) and
nalidixic acid (2800 micrograms/ml).

This phenomenon can be explained

if the relaxing activity of the topo II' is greater in this preparation
than the supercoiling activity of DNA gyrase.

In the absence of

pyridonecarboxyl ic acids, the v subunit relaxes DNA more efficiently
than DNA gyrase supercoils this same DNA, thus preventing the appearance
of

a

supercoiled

band.

At

higher

pyridonecarboxylic

acid

concentrations, the relaxing activity of topo II' may be inhibited to a
greater extent than the supercoiling activity of DNA gyrase and
intermediates

between

the completely supercoiled DNA

(DNA gyrase

reaction products), and completely relaxed DNA (topo II'

reaction

products) are observed.

RELAXATION OF SUPERCOILED DNA

P. aeruginosa DNA gyrase relaxed supercoiled DNA in the absence of
ATP (Figure 24, lane 2), but not in the presence of ATP (lane 3).

In
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1 2 3 4 5 6 7 8 9 10

Figure 23.

Inhibition of the Supercoiling Reaction by Pyridonecarboxylic Acids.

Topoisomerase I-relaxed Col El DNA was incubated with .a fresh preparation of DNA gyrase as described in the Methods section (lane 8).
Norfloxacin was added at a concentration of 0.4 µg/ml in lane 4.
Nalidixic acid was added at a concentration of 350 µl/ml in lane 5 and
1400 µl/ml in lane 6. Novobiocin was added to lane 7 at a concentration
of 10 µl/ml. Lane 9 contains no DNA and lane 10 contains supercoiled
DNA.
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1

Figure 24.

2

3

4

5

6

7

8

9

10

II 12

The Relaxation of Supercoiled DNA by P. aeruginosa DNA
Gyrase.
-

Supercoiled ~X174 DNA (lane 1, lower band) containing some relaxed DNA
(upper band) was incubated with f. aeruginosa DNA gyrase in the absence
of ATP (lane 2), in the presence of AppNp (lane 4), in the absence of
magnesium (lane 5), in the presence of norfloxacin at concentrations of
1.6 µl/ml (lane 6), 6.4 µg/ml (lane 7), 16 µg/ml (lane 8), and 100 µg/ml
(lane 9), in the presence of nalidixic acid at concentrations of 350
µg/ml (lane 10, and 700 µg/ml (lane 11), and in the presence of 100
µg/ml of novobiocin. The ladder of bands in between the relaxed and
supercoiled bands consists of topoisomers differing by two linking
numbers. Lanes 1-5 contain 0.5 µg of DNA, and lanes 6-12 contain 0.3 µg
of DNA.
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the presence of adenylyl-imidodiphosphate (AppNp) nonhydrolyzable analog
of ATP (lane 4), the relaxation occurred to a lesser extent that in its
absence.

The velocity of the relaxation reaction was measured as

described in the Methods section.

By measuring the velocity over time

for different substrate (supercoiled

~X174

DNA) concentrations and

graphing a Hanes plot of the results as described in the Methods section
(Figure 25), the Km of the relaxation reaction was determined to be
1.1 +/- 0.5 x 10- 9 Molar (3.82 +/- 1.2 x 10- 3 g/l).
The relaxation reaction was inhibited by norfloxacin (Figure 24,
lanes 6-9), and nalidixic acid (lanes 10 and 11), but not by novobiocin
(lane 12).

Increasing the concentration of norfloxacin or nalidixic

acid caused an increase in the extent of inhibition (lanes 6-9 and lanes
10 and 11, respectively).
presence

of

increasing

Carrying out the relaxation reaction in the
concentrations

of

pyridonecarboxylic

acid

resulted in an increase in the electrophoretic mobility of the ladder of
topoisomer bands (i.e., smaller extent of relaxation) and an increase in
the fraction of products located in the completely supercoiled band
(i.e., less molecules relaxed).
for relaxation on supercoiled
concentrations of norfloxacin.

Figure 26 demonstrates this phenomenon
~X174

DNA in the presence of increasing

The inhibition constants (Ki's) of the

pyridonecarboxylic acid derivatives on the relaxation reaction were
determined by carrying out the reaction in increasing concentrations of
drugs for sets of reactions containing differing concentrations of
supercoiled

~X174

Methods section.

DNA and calculating
the velocities as described in the
;
Dixon plots were drawn from the resulting data as

described in the Methods section. The Ki for norfloxacin was derived to
be 2.0 x 10- 3 Molar (650 micrograms/ml, Figure 27), 3.7 x 10- 3 Molar
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Figure 25.

Hanes Plot of the Relaxation Reaction.

The velocity (v) of the relaxation reaction was determined at varying
substrate concentrations (s) as described in the Methods section. s/v
is plotted against s and the x-intercept is equal to -Km. The three
different lines represent three different experiments performed on two
separately isolated prfparations. The average of the three x-intercepts
is 3.82 +/- 1.2 x 10- gl,1 since the molf9Cular weight of fl)X174 is 3.5 x
106 , the Km is equal to f.1 +/- 0.5 x 10- Molar.
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Figure 26.

Increasing Concentrations of Pyridonecarboxylic Acid Result
in Greater Inhibition of the Relaxation Reaction.

The relaxation reaction was carried out ·in the presence of norfloxacin
at concentrations of 1 µg/ml (lane 1), 250 µg/ml (lane 2), 500 µg/ml
(lane 3), 750 µg/ml (lane 4) and 1000 µg/ml (lane 5). An agarose gel of
the reaction products is on the right and a densitometric tracing of the
negative of the picture of this gel is on the left. R is the distance
migrated by completely relaxed DNA, and S is the distance migrated by
completely supercoiled DNA.
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Figure 27.

Dixon Plot of the Inhibition of P. aeruginosa DNA GyraseCatalyzed Relaxation by Norfloxacin.

The relaxation reaction was carried out in various §Oncentrations of
norfloxac:igl and substrate concentratiigt1S of 1.7 x 10- mMoles/ml (d}a
3.4 x 10- mMoles/ml (*), 6.9 x 10- mMoles/ml (O), and 1.8 x 10
mMoles/ml (~) as described in the Methods section.
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(975 micrograms/ml) for oxolinic acid (Figure 28), and 10.8 x 10- 3 Molar
(2500 micrograms/ml) for nalidixic acid (Figure 29).
A Cornish-Bowden plot (9) of the substrate concentration (s)
divided by the velocity (v) versus the inhibitor concentrations (i)
plotted at several (s) values will reveal what type of inhibition is
occurring.

If the lines are parallel, the inhibition is competitive.

If the lines intersect below the x axis, the inhibition is mixed, and if
the lines intersect above the x axis, the inhibition is uncompetitive.
Cornish-Bowden plots of the inhibition of relaxation by norfloxacin
(Figure 30), nalidixic acid (Figure 31), and oxolinic acid (Figure 32)
resulted in lines that appear to be parallel except for the lines at low
substrate concentrations. Analysis of covariance tests of the slopes of
all of the lines for each derivative indicate that the lines are not
parallel (Tables 9, 10, and 11).

The type of inhibition exerted by

these drugs may be different at low and high substrate concentrations,
however.

An analysis of covariance tests on a11 of the 1i nes for

norfloxacin excluding

the

line of

lowest

substrate concentration

indicates that the lines are significantly parallel (p < .01; Table 12).
This. indicates that the type of inhibition is competitive at higher
substrate

concentrations

and

uncompetitive

at

lower

substrate

concentrations.
Increasing concentrations up to 1 mg/ml of novobiocin did not
inhibit the relaxation reaction (Figure 22).

This is expected, since

novobiocin is an inhibitpr of the B subunit of DNA gyrase and the
relaxation reaction is a property of the A subunit.
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Figure 28. Dixon Plot of the Inhibition of P. aeruginosa DNA Gyrase.
Catalyzed Relaxation by Oxolinic-Acid.
The relaxation reaction was carried out in various ~ncentrations of
oxolinic ~id and substrate concentrat~ons of 1.7 x 10- mMoles/ml (1t1
3.4 x 10- mMoles/ml (0), 6.9 x 10- ntloles/ml ( 0), and 1.8 x 10 8
mMoles/ml (~) as described in the Methods section.
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Figure 29.

1

Dixon Plot of the Inhibition of ~· aeruginosa DNA GyraseCatalyzed Relaxation by Nalidixic Acid.

The relaxation reaction was carried out in various concen~rations of
nalidixic acid ~d substrate concentrations of lg7 x 10- ti1Md11:!s/ml
(*), 3.4 x 10- mMoles/ml (0), and 6.9 x 10- mMoles/ml (e) as
described in the Methods section.
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Figure 30. Cornish-Bowden Plot of the Relaxation Reaction in the
Presence of Norflosacin.
The concentration of supercoiled ~X174 DNA (s) divided by the velocity
of the relaxation reaction (v) catalyzed by P. aeruginosa DNA gyrase is
plotted against the concentration of nor1foxacin (1) added. ·The
different ~in es represent different con~·gmtra ti ons of substrate: ( ~
1.7 x 10- mMoles/ml, (0}. 3.4 x 10- mMoles/ml, (O) 6.9 x 10mMoles/ml, and(~) 1.8 x 10 8 mMoles/ml.
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Figure 31. Cornish-Bowden Plot of the Relaxation Reaction in the
Presence of Oxolinic Acid.
The concentration of supercoiled ~Xl74 DNA (s) divided by the velocity
of the relaxation reaction (v) catalyzed by P. aeru inosa DNA gyrase is
plotted against the concentration of oxol1nic ac1
1 added. The
different gi nes represent different con~ntrations of substrate: (*~
1.7 x 10- mMoles/ml, (0) 3.4 x 10- mMoles/ml, (e) 6.9 x 10mMoles/ml, and (O), 1.8x10-8 mMoles/ml.
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Figure 32. Cornish-Bowden Plot of the Relaxation Reaction in the
Presence of Nalidixic Acid.
The concentration of supercoiled ~X174 DNA (s) divided by the velocity
of the relaxation reaction (v) catalyzed by P. aeruginosa DNA gyrase is
plotted against the concentration of nalidlxic acid (i) added. The
different 9lines represent different c~ncentrations of substrate: (*~
1.7 x 10- mMoles/ml, (0) 3.4 x 10- mMoles/ml, and (0) 6.9 x 10mMoles/ml.
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Table 9.

Analysis of the Covariance on the Slopes of the Cornish-Bowden Plots for Norfloxacin

x
Obs
Obs
Obs
Ob·s
Obs
Obs
Obs
Obs
Obs
Obs

I

2
3
4
5
6
7
8
9
10

(X=
(X**2=
[Y=
(Y**2=
[XY=
Mean X=
Mean"Y=
N=
Byx=
Fb=

Group I

0
250
500

750
312500
5549.2
250

y

5.3154
6.9412
7.6278

19.8844
134.61706
6.6281333

3
0.0046248NS
2.7313321

x

Group JI

0
250
500
750

1500
875000
27415
375
4
0 .OllNS
8.3566657

y

x

10.82
16.41
16.88
19.83

0
250
500
750
1000

63.94
1064.5238

Group Ill

y

x

17.79
24.42
28.18
34.79
35.17

0
10
25
50
75
100
250
500
750
1000

2500
1875000

2760
1893850

625000
11282. 5
214.5814

1132090
11349.667
123 .27177

Group Iv

y

14.581
14.514
15.895
15.101
13.368
14.222
16.601
18.406
20.484
25.451

140.35
168.623
4154.2059
2966.6433
81457.5
57889.615
500
276
15.985
28.07
16.8623
5
10
0.018052*
0.0100254**
17.252357
11.825165

f X*2-Cxx)

XY=Cxy
[Y*2=Cl'.l'.

125000
578.1
2.8206129

Cxxw=
Cxyw=
Cn!:!=

2194590
26647.767
383.11668

Cxxb=
Cxyb=
Cub=

198119 .09
11576. 799
923.70085

Cxxt=
Cxyt=
cut=

2392709.0
38224.566
1306.8175

FN 1=
rn:::2=

bw=

0.0121424

S_l=

34.372857

S_2=

25.173827

F=

312500
3437.5
42.4429

SUM

7510

~956350

392.7974
8319.9901
172311.31
341. 36363
17 .854427
22

3
14
6.3719620**

Table 9. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Norfloxacin.
The line labelled Byx represents the slope for the individual groups. The line below, labelled Fb,
provides the F-statistics to test whether these individual slopes differ significantly from zero. The
critical information is the F-statistics in the lower right hand corner of the table. If that
statistic is significant, the slopes vary significantly among the groups. The null-hypothesis assumes
that the regress i ans based on the separate groups are the same as that based on the total group,
except for sampling variability, and that therefore the effects of different concentrations of
substrate can be disregarded. If the F-statistics is significant, then the slopes vary significantly
among the groups, and from the common slope, bw, hypothesized to exist for the groups combined. The
number in the left bottom corner is the common slope bw. Thus the hypothesis being tested is:
b = b = b = b = b • NS indicates that a particular F-statistic is not significant, the symbol *
i~dicafes trlat i~ is ~ignificant at the .05 level, and** indicates significance at the .01 level.
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Table 10. Analysis of the Covariance on the Slopes of the Cornish-Bowden Plots for Oxolinic Acid

x
Obs
Obs
Obs
Obs
Obs
Obs
Obs
Obs
Obs
Obs

1
2
3
4
5
6
7
8
9
10

[X=
[X**2=
[Y=
[Y**2=
[XY=
Mean X=
Mean'.:::V=
N=
Byx=
Fb=
X*2-Cxx)
XY=Cxy
Y*2=C

Group I

0
250
750
1000

y

x

13.9
15.4
21.5
50.8

125
375
625
875

Group II

y

27.6
31.6
29.6
38.5

x

Group III

250
500
1000

y

x

54.4
66.7
70

0
10
25
75
750
1000

2000
1625000

2000
1312500

1750
1312500

1860
1568850

625000
19975
892.62

312500
3837.5
67 .4075

291666.66
5475
135.18

992250
3516.14
13.636792

Group IV

y

SUM

11. 576
12.212
12.628
12.486
14.066
16.105

7610
5818850
127.3
499.073
101. 6
191.1
79.073
3473.26
4118.73
12308.25
1055.7266 20955.966
116950
28028.77
283241.27
70775
67487.5
310
500
500
583.33333
25.4
31.825
13.178833
63.7
4
4
3
6
17
0.03196NS
0.01228NS
0.0187714NS
0.0035436NS
15. 778014
10.700624
5.5211064
3.6092507

Cxxw=
Cxyw=
Cy_y_w=

2221416.6
32803.64
1108.8442

bw=

0.0147669

Cxxb=
Cxyb=
Cy_y_b=

s

l=

190839.21
27029.069
5195. 7188

Cxxt=
Cxyt=
Cy_y_t=

2412255.8
59832.709
6304.5631

FN 1=
FN-2=

316.34781

S_2=

308.08541

F=

3
9
3.0804556NS

Table 10. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Oxolinic Acid.
The line l abe 11 ed Byx represents the slope for the individual groups. The 1i ne be 1ow, 1abe11 ed Fb,
provides the F-statistics to test whether these individual slopes differ significantly from zero. The
critical information is the F-statistics in the lower right hand corner of the table. If that
statistic is significant, the slopes vary significantly among the groups. The null-hypothesis assumes
that the regressions based on the separate groups are the same as that based on the total group,
except for sampling variability, and that therefore the effects of different concentrations of
substrate can be disregarded. If the F-statistics is significant, then the slopes vary significantly
among the groups, and from the common slope, bw, hypothesized to exist for the groups combined. The
number in the left bottom corner is the common slope bw. Thus the hypothesis being tested is:
b = b = b = b = b • NS indicates that a particular F-statistic is not significant, the symbol *
iAdicates t~at if is ~ignificant at the .05 level, and** indicates significance at the .01 level.
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Table 11. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Nalidixic Acid

x
Obs
Obs
Obs
Obs
Obs
Obs
Obs
Obs
Obs
Obs

1
2
3
4
5
6
7
8
9
10

0
500
750
1000

fx-X**2=

2250
1812500

[Y=
[Y**2=
[XY=
Mean'-X=
Mean-Y=
N=
Byx=
Fb=

fX*2=Cxx
XY=Cxy
[Y*2=Cu
Cxxw=
Cxyw=

39260
562.5

Group I

y

x

6.8
7.4
7.52
29.92

0
250
500
750

51.64
1052.7568

4
0.0186742NS
9.4048879

12.91

C~y_w=

bw=

0.0115169

1500
875000
22975
375
4
0.00248NS
4.3387025

y

x

13.5
14.3
16.6
14.8

0
125
375
625

59.2
881.34
14.8

312500
775
5.18

546875
10212.5
386.0844
1089843.7
12551. 625
409.56082

Group II

Cxxb=
Cxyb=
Cy_y_b=

s

1=

164062.5
-10148.35
957 .60871
58.692558

Group II I

1125
546875
38390.1
281. 25
4
0.0067867NS
3.3488856

y

SUM

30 .144
31.368
35.6856
33.7392

130.9368
4304.4078

4875
3234375
241. 7768
6238.5046
100625.1

32.7342

12

230468.75
1564.125
18.296425
Cxxt=
Cxyt=
C~y_t=

s

2=

1253906.2
2403.275
1367.1695

FN 1=
FN-2=

206.31241

F=

3
4
0.3793118NS

Table 11. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Nalidixic Acid.
The 1i ne 1abel1 ed Byx represents the s 1ope for the i ndi vi du a1 groups. The 1i ne be 1ow; 1abel led Fb,
provides the F-statistics to test whether these individual slopes differ significantly from zero. The
critical information is the F-statistics in the lower right hand corner of the table. If that
statistic is significant, the slopes vary significantly among the groups. The null-hypothesis assumes
that the regressions based on the separate groups are the same as that based on the total group,
except for sampling variability, and that therefore the effects of different concentrations of
substrate can be disregarded. If the F-statistics is significant, then the slopes vary significantly
among the groups, and from the common slope, bw, hypothesized to exist for the groups combined. The
number in the left bottom corner is the common slope bw. Thus the hypothesis being tested is:
b = b = b = b = b • NS indicates that a particular F-statistic is not significant, the symbol *
i~dicates tKat i~ is ~ignificant at the .05 level, and** indicates significance at the .01 level.
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Table 12. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Norfloxacin
at Higher Substrate Concentrations Only

x
Obs
Obs
Obs
Obs
Obs
Obs
Obs
Obs
Obs
Obs

0
250
500

1
2
3
4
5
6
7
8
9
10

(X=

~X**2=

750
312500

Y=
P**2=
XY=
Mean"-X=
Mean-Y=
N=
Byx=
Fb=

Group

y

x

5.3154
6.9412
7.6278

0
250
500
750

19.8844
134.61706

5549.2
250

6.6281333
3
0.0046248NS
2.7313321

[X*2=Cxx
125000
(XY=Cxy
578.1
[Y*2=C,U 2.8206129
Cxxw=
Cxyw=
Cy_y_w=

1062500
15298.1
259.84491

bw=

0.0143982

Group I I

1500
875000
27415
375
4
0.011NS
8.3566657

y

x

10.82
16.41
16.88
19.83

0
250
500
750
1000

63.94
1064.5238
15.985

s

l=

81457.5
500

y

SUM

17.79
24.42
28.18
34.79
35.17

140.35
4154.2059

4750
3062500
224.1744
5353.3467
114421. 7

28.07
12

5
0.018052*
17.252357

312500
3437.5
42.4429
Cxxb=
Cxyb=
Cn:b=

2500
1875000

Group III

625000
11282. 5
214.5814

119791.66
10387.9
905.65505

Cxxt=
Cxyt=
Cn:t=

1182291.6.
25686
1165.499

FN l=
FN-2=

23.892503

S_2=

15.687126

F=

3
4
2.0307525NS

Table 12. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Norfloxacin
at Higher Substrate Concentrations Only
The line labelled Byx represents the slope for the individual groups. The line below, labelled Fb,
provides the F-statistics to test whether these individual slopes differ significantly from zero. The
critical information is the F-statistics in the lower right hand corner of the table. If that
statistic is significant, the slopes vary significantly among the groups. The null-hypothesis assumes
that the regressions based on the separate groups are the same as that based on the total group,
except for sampling vari abi 1ity, and that therefore the effects of different concentrations of
substrate can be disregarded. If the F-statistics is significant, then the slopes vary significantly
among the groups, and from the common slope, bw, hypothesized to exist for the groups combined. The
number in the left bottom corner is the common s 1ope bw. Thus the hypo thesis being tested is:
b1 = b = b = b = b . NS indicates that a particular F-statistic is not significant, the symbol *
indica~es t~at it is ~ignificant at the .05 level, and** indicates significance at the .01 level.
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Figure 33. Plot of the Velocity of the Relaxation Reaction in the
Presence of Novobiocin.
The velocity of the relaxation reaction catalyzed by P. aeruginosa DNA
gyrase is plotted against the concentration of novobiocln (i) added.
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CATENATION REACTION

An agarose gel of the products from the supercoiling reaction
exhibited a band of lower electrophoretic mobility (Figure 34).

This

band may consist of concatamers of the circular DNA, since catenated
circular DNA has been shown to have lower electrophoretic mobility than
relaxed DNA on an agarose gel (42). This band may not be due to protein
bound DNA since these reactions were extracted with a mixture of
chloroform and isopropanol before loading the gel.

CLEAVAGE OF DNA

Incubation of DNA gyrase with pyridonecarboxylic acid for one hour
at 37° C with subsequent incubation in the presence of SOS resulted in
cleavage of the relaxed and linear DNA with little if any cleavage of
the supercoiled DNA (Figure 35, lanes 3-8).

ATP (lane 7) and AppNp

(lane 8) did not prevent the cleavage but inhibited it slightly.

The

DNA migrated to the same distance in the presence and absence of
proteinase K digestion (lanes 3 and 4, respectively).

This suggests

that no protein is attached to the cleaved DNA, but the gel may not be
sensitive enough to show the slight difference in migration.

The fact

that the cleavage product consists of two bands (which are hard to
distinguish in Figure 35 but can be seen in the densitometric tracing)
which migrate faster than linear DNA (lane 10) indicates that DNA gyrase
cleaves the DNA in two places.
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1

Figure 34.

2

3

4

6

The Catenation Reaction of

7

~·

8

9

aeruginosa DNA Gyrase.

P. aeru~inosa DNA gyrase was incubated with relaxed ~X174 DNA as
describe for the supercoiling reaction in the Methods section. Lane 1
contains relaxed DNA incubated in the absnece of DNA gyrase and lane 9
contains supercoiled DNA. Lanes 2-8 contain relaxed DNA incubated with
one unit of DNA gyrase.
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f
Figure 35.

I

Cleavage of DNA by ~· aeruginosa DNA Gyrase in the Presence
of Pyridonecarboxylic Acid and SOS.

The 0X174 DNA used in this reaction is seen in lane 1, the upper band is
relaxed, closed circular DNA, the middle band is linear DNA, and the
1ower band is supercoil ed DNA. When this DNA is incubated with P.
aeruginosa DNA gyrase in the absence of drug, a ladder of bands between
the linear and supercoiled which consists of different topoisomers
differing by two linking numbers can be seen (lane 2). When the DNA is
incubated with pyridonecarboxylic acid followed by incubation in the
presence of SOS as described in the text, two bands (which are hard to
distinguish in this photograph) consisting of cut linear DNA can be seen
(lanes 3-8). Norfloxacin (lanes 3 and 4), nalidixic acid (lane 5),
oxolinic acid (lanes 6-9) or novobiocin (lane 9) was used. Proteinase K
(lane 5), ATP (lane 7) or AppNp (lane 8) was added to the reaction as
described in the text. Linear 0X174 DNA is in lane 10. The inset is a
densitometric tracing of lane 3. R is the distance migrated by
completely relaxed DNA and S is the distance migrated by completely
supercoiled DNA.
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ATPase REACTION

ATP hyrolysis was examined by measuring the amount of inorganic
phosphate released during the supercoiling reaction.

This was detected

by reading the absorbance at 660 nanometers (A 660 ) of the supercoi 1i ng
reaction mixture incubated at 37° C for 30 minutes and treated with
co 1or reagents as described in the Methods sect ion.

The A660 of the
supercoiling reaction mixture was not significantly different from the

A660 of the controls lacking DNA gyrase or ATP (Table 13). The A660 of
the inorganic phosphate standards was directly proportional to the
concentration of inorganic phosphate (Figure 36).

No ATPase activity

was detected in either fresh or frozen DNA gyrase preparations.

One

unit of M. luteus DNA gyrase (Bethesda Research Laboratories) and
incubated in the supercoiling reaction mixture containing 0.5 micrograms
of relaxed 9JX174 DNA exhibited detectable ATPase activity (2 x 10- 6
moles of inorganic phosphate released per minute) which was inhibited by
10 micrograms/ml of novobiocin.
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Table 13. ATPase Reaction

Experiment

Sample

OD660

1

Supercoiling reaction
Control, no DNA gyrase
Control, no ATP

3.142 +/- 0.009
3.224 +/- 0.003
3.284 +/- 0.003

2

Supercoiling reaction
Control, no DNA gyrase
Control, no ATP

2.821 +/- 0.089
2.850 +/- 0.021
2.862 +/- 0.013

3

Supercoiling reaction
Control, no DNA gyrase
Control, no ATP

2.067 +/- 0.062
2.098 +/- 0.093
2.054 +/- 0.009

4

Supercoiling reaction
Control, no DNA gyrase
Control, no ATP

2.015 +/- 0.013
2.098 +/- 0.093
2.017 +/- 0.011

5

Supercoiling reaction
Control, no DNA gyrase
Control, no ATP

2.954 +/- 0.022
2.979 +/- 0.018
2.986 +/- 0.052

Supercoiling reaction
Control, no DNA gyrase
Control, no ATP
Supercoiling reaction +
novobiocin*

3.180
2.979
2.986
3.077

P. aeruginosa DNA gyrase:

M. luteus DNA gyrase:
1

*10 micrograms/ml

+/- 0.024
+/- 0.028
+/- 0.052

+/- 0.033
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Figure 36. Calibration Curve for the Concentration of Inorganic
Phosphate.

DISCUSSION

IN VIVO EFFECTS OF PYRIDONECARBOXYLIC ACIDS ON P. AERUGINOSA

Pseudomonas

aeruginosa

is more

resistant

to

norfloxacin and

nalidixic acid than Escherichia coli {Table 9 and reference 30).
two pyridonecarboxylic acid derivatives affect

f.

These

aeruginosa similarly,

since spontaneous mutants resistant to norfloxacin, RM166, 167, 168, and
169, are also resistant to nalidixic acid, and a nalidixic acid
resistant mutant, RM4000, is also resistant to norfloxacin (Table 9).
This suggests that the two derivatives have the same mechanism of
transport into the cell, they have the same target of action, or both.
Since pyridonecarboxyl ic acids inhibit

~·

coli DNA gyrase and a

nalidixic acid-sensitive DNA gyrase has been purified from

f.

aeruginosa

{56), the site of action of these drugs is most likely DNA gyrase bound
to the chromosome.

DNA gyrase is required for DNA replication {36) and

pyridonecarboxylic acids inhibit DNA synthesis {22,25).

Therefore, it

would be expected that these drugs would be most potent when DNA
replication is most active and when the activities of DNA gyrase are
clearly needed in early to mid-log phase of an logarithmically growing
culture, and less potent when there is little if any DNA replication in
late log phase.

Treatment of a culture of

f.

aeruginosa in early log

phase with norfloxacin causes a significant inhibition of growth {Figure
4).

Treatment of this culture in ·1ate log phase causes much less

inhibition of growth {Figure 5).
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P. aeruginosa cultures treated with bactericidal concentrations of
pyridonecarboxylic acids exhibit lethal unbalanced growth.

This is a

deregulation of the normal growth cycle where cells that are no longer
viable undergo cell division and filamentation.

Filamentation is an

elongation of the cell which keeps the surface to volume ratio constant.
This allows the extra chromosomes synthesized in the absence of ce 11
division to be distributed along the cell membrane.

Both PA0303 and RMB

exhibit cell division after 24 hours of treatment with norfloxacin or
nalidixic acid and RMB filaments when treated with nalidixic acid
(Figure B).

This

lethal

unbalanced

growth may

result from the

prevention of the completion of a round of chromosome replication by
pyridonecarboxylic acids since this completion has been suggested to
trigger the initiation of septation which precedes cell division (15).
Pyridonecarboxylic acids may prevent the induction of a cell division
regulating signal by preventing the completion of a round of chromosome
replication.
Alternatively,

lethal

unbalanced

growth

may

result

from

pyridonecarboxylic acids effect on gene expression (reviewed in lB).
Treatment with pyridonecarboxylic acids causes a decrease in the
synthesis of outer membrane proteins in comparison to the synthesis of
inner membrane proteins ( 2B).

Si nee a sudden exponent i a1 increase in

the synthesis of outer membrane proteins has been observed just before
cell division (4), pyridonecarboxylic acids could deregulate the cells
growth cycle by inhibiting the expression of outer membrane proteins.
Also, these drugs may alter the expression of a protein which regulates
cell division and thus allowing some bf the cells to divide even though
the division would not result in two viable cells.

Therefore, the
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mechanism of drug induced cell death may be the inhibition of the
expression of specific genes which are vital to the cell.
The bactericidal activity of pyridonecarboxylic acids in ,;_. coli
has been shown to require competent RNA and protein synthesis (76,84).
Simultaneous

treatment

of

P.

aeruginosa

with

chloramphenicol

or

rifamycin, inhibitor of protein and RNA syntheses, respectively, along
with pyridonecarboxylic acid alleviates the bactericidal effect of the
pyridonecarboxylic acid (Figures 6A and 7A).

This protection suggests

that there may be a gene responsible for killing whose expression is
induced upon drug treatment and therefore, by preventing the expression
of this gene, chloramphenicol prevents killing.

RECOVERY SYNTHESIS

In a logarithmically growing culture, the rate of DNA synthesis as
followed by pulse labeling DNA increases logarithmically (Figure 11).
Pyridonecarboxylic acid treatment causes an immediate inhibition of the
rate of DNA synthesis.

Within 5 minutes, however, the rate of DNA

synthesis is again increasing logarithmically.
exponential

I will term this second

rate of DNA synthesis "recovery synthesis."

Recovery

synthesis is observed at concentrations below the MBC and not at the
MBC.
Pyridonecarboxylic acids may act by binding to DNA at sites
complexed with DNA gyrase thereby creating complexes that block the
movement of the replication fork (19).

Also, these drugs inhibit- the

activities of DNA gyrase which is part of the enzyme system required for
replication (36).

Therefore, in order for recovery synthesis to occur,
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a repair system to remove the hypothesized drug-DNA gyrase complex and
repair the DNA may be needed.

Recovery synthesis may also require the

synthesis of new DNA gyrase molecules to replace those inactivated by
drug.
If recovery synthesis results from an inducible repair system, then
simultaneous treatment with drug and chloramphenicol, an inhibitor of
protein synthesis, will prevent the synthesis of the necessary proteins
and recovery synthesis should not be observed.

Simultaneous treatment

with pyridonecarboxylic acid and chloramphenicol does prevent recovery
synthesis in PA0303 (Figure 13A).

In this case, the initial rapid rate

of inhibition of DNA synthesis is followed by a slower rate of
inhibition. When these cultures are treated with chloramphenicol alone,
the rate of DNA synthesis also decreases.

This suggests that the

enzymes required for the exponential rate of DNA synthesis must be
continually synthesized.
The fact that protein synthesis is required for both killing and
recovery synthesis suggests that the induced genes which are responsible
for these two phenomena may be under the same control or in fact may be
the same gene.

Perhaps it is the DNA gyrase gene itself.

Since DNA

gyrase is required for DNA replication, it follows that it would also be
required for recovery synthesis because DNA synthesis occurs during both
recovery synthesis and DNA replication.

Synthesis of new DNA gyrase

molecules in a pyridonecarboxylic acid treated cell may be lethal since
this would result in more drug-DNA gyrase complexes on the chromosome
which will inhibit replication.

Also, the synthesis of new DNA gyrase

molecules may alter the superhelical density of the chromosome and
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result in a greater effect on gene expression which could be lethal to
the cell.

THE MECHANISM OF RECOVERY SYNTHESIS
What happens inside a f. aeruginosa cell in the five minutes it
takes to overcome the inhibiting effects of pyridonecarboxylic acids and
start recovery synthesis? How are the drug-DNA gyrase complexes removed
from the DNA?

Is more DNA gyrase synthesized, or can the old DNA gyrase

molecules be freed from the pyridonecarboxylic acids?
In order to answer some of these questions, the effects of
pyridonecarboxylic

acids

on

P.

aeruginosa

mutants

deficient

in

recombination (a Rec- phenotype) were also studied; PA02002, a Recmutant of PA02001, which is less resistant to nalidixic acid than its
parent and RMB, a Rec- mutant of PA0303, which is more resistant to
norfloxacin and nalidixic acid than its parent.

If a recombinational

DNA repair system were used to remove drug-DNA gyrase complexes, then
recovery synthesis would not be observed in ·these mutants.

These

mutants are of interest to study a1 so because they are deficient in
lysogeny establishment of phage (a Les- phenotype) and DNA gyrase is
required for lysogenic establishment of prophage lambda into the E. coli
chromosome (57).
As expected, PA02002 (Rec-) does not exhibit recovery synthesis
(Figure 148 and D).

After a five minute initial phase of rapid

inhibition, the rate of DNA synthesis decreases at a slower rate.
Biphasic inhibition kinetics is also observed when PA0303 is treated
simultaneously with pyridonecarboxylic acid and chloramphenicol (Figure
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13A):

an initial rapid rate of inhibition is followed by a slower rate

of inhibition.
Why are there two distinct rates of inhibition in the absence of
recovery synthesis as in the case of PA02002 and chloramphenicol-treated
PA0303?

If

DNA gyrase binds to DNA approximately every 100 ki l obase

pairs (17), then the replications forks would stop whenever they reached
a drug-DNA gyrase complex that had not yet been removed and monophasic
inhibition kinetics would be expected.

But there is evidence that DNA

gyrase binds at or near the replication forks in addition to binding
approximately every 100 kilobasepairs and this could explain the
biphasic inhibition kinetics (17). The initial rapid rate of inhibition
may be due to drug-DNA gyrase complexes occurring at the replication
fork.

The slower rate of inhibition may be the result of replication

forks which escaped the drug proceeding until they reached a drug-DNA
gyrase complex on the DNA or until the terminus of replication.
From the hypothesis that the initial inhibition is due to drug-DNA
gyrase complexes occurring at the replication fork, it would follow that
one can titrate replication forks on DNA with the drug-DNA gyrase
comp 1exes.

If

this is true, then one would expect that for a given

bacterial strain, the degree of inhibition should be the same for both
norfloxacin and nalidixic acid provided the concentrations of both drugs
is sufficiently high (e.g., four times the MIC).

As seen in Figures 11

and 12, at a concentration of four times the MIC, nalidixic acid
initially inhibits DNA synthesis to a greater extent than norfloxacin.
The MIC's for norfloxacin and nalidixic acid are very different.
This may be due to the fact that the· drugs' effects on other processes
besides DNA synthesis are involved in the inhibition of growth.

The
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concentration at which RNA and protein synthesis are inhibited most
likely also play a role in the minimal concentration required to inhibit
growth because the concentration at which RNA and protein synthesis are
inhibited is greater than the concentration at which DNA synthesis is
inhibited (76).

The inhibition of protein synthesis may play a role in

the rate of DNA synthesis because enzymes involved in DNA synthesis need
to be made.

Also, since release of RNA from the chromosome requires

translation in a prokaryotic cell (48), drug-inhibited translation may
block replication.

Since nalidixic acid and norfloxacin inhibit protein

synthesis to different extents at the concentration of four times the
MIC (Figure 9), the same extent of DNA synthesis inhibition is not
expected for this concentration of each drug.

Since nal idixic acid

inhibits protein synthesis to a greater extent than norfloxacin, it
would be expected to have a greater effect on DNA replication than
norfloxacin.

Norfloxacin would be expected to have a greater initial

inhibitory effect on DNA replication if protein synthesis was inhibited
simultaneously

with

norfloxacin

treatment.

This

is

comparing the initial inhibitions in Figure 11 and 13.

observed

by

This data is

summarized in Table 14.
The biphasic inhibition kinetics can also be explained another way.
Perhaps the initial rapid rate of inhibition is due to the inactivation
of DNA gyrase on the chromosome causing an
existing rep 1 i ca ti on forks.

immediate stop to the

DNA synthesis during the second phase is

1 imited to DNA stretches unbound by drug-DNA gyrase mo 1ecul es and can
only utilize the activity of the DNA gyrase complexes left unaffected by
the drug.

The creation of new replication forks is probably required

for this second phase.

In the case of the Rec- mutant, recovery
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Table 14.

Initial Inhibitions (percent)

Strain

Nalidixic
acid

Norfloxacin

Norfloxacin and
Chloramphenicol

PA 0303

80

50

60

RMB

75

30

40

PA02001

85

30

ND

PA02002

80

40

ND

This data is summarized from Figures 11 t 12, 13, and 14.
ND = Not determined.
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synthesis does not occur because the drug-DNA gyrase complexes are not
being removed from the chromosome.
simultaneously

with

chloramphenicol

In the case of PA0303 treated
and

pyridonecarboxylic

acid,

recovery synthesis does not occur because new DNA gyrase molecules can
not be synthesized.

RMB: A SPECIAL CASE

The other Rec- mutant RMB surprisingly exhibited recovery synthesis
in the presence of norfloxacin (Figure 118).

It also exhibited recovery

synthesis in the presence of nalidixic acid, but this recovery synthesis
could not be sustained (Figure 128).

Since nalidixic acid inhibits

protein synthesis about 99%, it probably does not allow the synthesis of
large enough quantities of the required enzymes to support recovery
synthesis. Since norfloxacin inhibits protein synthesis only about 50%,
it a11 ows the synthesis of enough of the required enzymes to support
recovery synthesis.
If recombination is required for recovery synthesis, then why does
recovery synthesis occur in RMB if it is deficient in recombination,
while the other Rec- strain (PA02002)
synthesis?

does not exhibit recovery

It is very likely that some of the enzymes involved in

recombination are also actively involved in recovery synthesis as well
and if RMB is deficient .in these enzymes, then it should also be
deficient in recovery synthesis.

The recombinational deficiency in RMB

may not be due to lacking or inactive recombinational enzymes.

Perhaps

RMB is different from the wild type cell because it constitutively
synthesizes a low amount of the necessary enzymes which may be enought
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for some recovery synthesis to occur but not enough for recombination,
whereas

its

parent,

PA0303,

only synthesizes these enzymes

upon

induction by pyridonecarboxylic acids (Figures llA, 12A, and 13A).

To

test this, RM8 was treated simultaneously with chloramphenicol and
norfloxacin.

In this case, recovery synthesis occurred but could not be

sustained (Figure 138).

The DNA synthesis curve looked very similar to

the DNA synthesis curve of nalidixic acid alone (Figure 128).
inhibiting protein synthesis at the same time as

By

treatment with

norfloxacin, the effects of nalidixic acid were mimicked. This supports
the previously mentioned data that nalidixic acid inhibits protein
synthesis 99%, while norfloxacin inhibits protein synthesis only about
50% (Figure 9).
If inhibition of protein synthesis prevents recovery synthesis,
then why does recovery synthesis occur in PA0303 treated with nalidixic
acid if nalidixic acid inhibits protein synthesis 99%?

Chloramphenicol

inhibits initiation of protein synthesis while allowing elongation of
previously initiated amino acid chains to continue.
nalidixic acid inhibits protein synthesis.

It is not known how

Nalidixic acid may inhibit

protein synthesis by inhibiting elongation of amino acid chains since
the full inhibitory effect of this drug is not felt until 10 minutes
after treatment. (Figure 9).

Under this hypothesis, the induced proteins

will be initiated and elongation of enough proteins to perform recovery
synthesis might occur in the presence of nalidixic acid.

Small

concentrations of these proteins may be sufficient to perform recovery
synthesis, since the low levels of these proteins postulated to be
present in RM8 are sufficient for recovery synthesis but not sufficient
to make this strain recombinationally proficient.
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Thus, PA02001 and PA0303 exhibit recovery synthesis because they
synthesize the required enzymes upon induction by drug.

The required

enzymes inc 1ude at 1east some of the enzymes that are involved in
recombination.

PA02002 may not exhibit recovery synthesis because its

recombination enzymes are inoperative or lacking.

RMB may synthesize

recombination enzymes at levels too low for this strain to be considered
recombinationally proficient, but in the presence of sufficient protein
synthesis, enough of these enzymes may be made to a11 ow some recovery
synthesis to occur.
The enzymes involved in both recombination and recovery synthesis
most likely would contain exonuclease and polymerase activities if the
recovery mechanism is to cut out pieces of DNA bound by drug-DNA gyrase
complexes. Alternatively, the enzymes may contain supercoiling activity
that may cause the complex to fall off the chromosome.

This may be

true, since gyrase binds less well to supercoiled DNA than to relaxed.
The bactericidal activity of pyridonecarboxylic acids in RMB is not
alleviated by inhibiting protein or RNA synthesis simultaneously with
drug treatment (Figures 68 and 78, respectively}.

This suggests that

the protein(s} responsible for killing is present before drug treatment.
The observation that RMB naturally has a high percentage of dead cells
(56} supports this hypothesis.

Since PA0303 synthesizes the protein

responsible for killing only upon induction (Figures 6A and 7A}, the
observation that killing in RMB is not alleviated by chloramphenicol
supports the hypothesis that RMB s mutation is constitutive.
1

RMB filaments when treated with nalidixic acid but not when treated
with norfloxacin (Figure BD and F). This is surprising, since nalidixic
acid

inhibits

protein

synthesis

to

a greater

extent

than

does
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norfloxacin (Figure 9). This supports the hypothesis that filamentation
is caused by a more complex mechanism than the mere inhibition of
replication in the presence of continued RNA and protein synthesis.

INDUCTION OF DNA REPAIR

Treatment of -E. -coli with nalidixic acid has been shown to induce
the synthesis of the RecA protein (25,26), which controls the expression
of and/or is involved in all of the dark DNA repair pathways known to
exist in E. coli

(82).

Nalidixic acid treatment also induces a

mutagenic repair pathway in£_. coli that will repair UV-damaged phage
DNA (69).

This is detected by infecting nalidixic acid-treated cells

with UV-damaged phage and determining how many phage survive.

If a DNA

repair pathway has been induced by the drug treatment, then the number
of PFU s in the treated culture will be exponentially greater than the
1

number of PFU 1 s in the control untreated culture.

The DNA repair

pathway induced in £_. coli is mutagenic, because the number of plaques
with altered phenotypes found among the reactivated plaques is in
proportion to the extent of reactivation (69).
Similar results would be expected when these experiments are
repeated with

E·

aeruginosa, since

E·

aeruginosa possesses a

~

protein which restores Rec+ phenotypes to Rec- E. coli cells (42).
Neither norfloxacin nor nalidixic acid induced increased repair or
mutagenesis of UV-damaged phage D3 in PA0303 or RM8 (Figure 16).

This

is not completely unexpected, however, since ultraviolet irradiation
does not induce repair or mutagenesis of UV-damaged phage D3 in these
strains either (72).

Speculation on the method used to remove drug-DNA
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gyrase complexes from the chromosome in
knowledge of the

f.

f.

aeruginosa must await further

aeruginosa DNA repair pathways.

P. AERUGINOSA DNA GYRASE AND TOPO 11'

Even though pyridonecarboxylic acids bind to DNA instead of DNA
gyrase (70), their ultimate effect is to i_nhibit the activities of the A
subunit and DNA gyrase (22).

Therefore, in order to further study the

mechanism of action of pyridonecarboxyl ic acids in f. aeruginosa, I
isolated DNA gyrase from strain PA0303 and tested the in vitro effects
of these drugs on the purified preparation.

f.

aeruginosa DNA gyrase has been isolated previously by Miller and

Scurlock (56), who used a series of three columns for the purification.
After minimal success with this method, I attempted to adapt the method
of Staudenbauer et !!_. (76).

Using a novobioci n-Sepharous affinity

column, I was able to improve the specific activity from 15,000 units/mg
protein to 37,000 units/mg protein.
P. aeruginosa DNA gyrase protein is similar to the

~·

coli DNA

gyrase protein in that it consists of two subunits with molecular
weights of approximately 95,000 and 105,000 (Figure 17). Since the
molecular weight of the holoenzyme is 3.6 ~ .3 x 105 (50), it most
likely consists of two molecules of each of the two subunits. Two lower
molecular weight proteins are also present in the purified preparation
at lower concentrations.

I suspect that these other proteins may be

proteolytic products of the B subunit similar to
of topo 11' for the following reasons:

the~-

coli v subunit
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1. No ATPase activity was detected in the DNA gyrase preparation
{Table 13), and£. coli topo II' has no ATPase activity.
2. ATP does not alter the DNA cleavage pattern within the limits of
detection available in the system used {Figure 35).

ATP is known

to alter the cleavage pattern of DNA gyrase but not of topo II' in
coli.
-E. -3. After freezing or after 24 hours of storage at 4° C, the DNA gyrase
preparation loses its supercoil ing activity and only cleaves the
DNA with a double-stranded cut without completing the reaction
{Figures 19 and 22).

In£. coli, DNA gyrase cleaves less than one

percent of the DNA in a supercoiling reaction mixture {77), and
topo II' cleaves all of the effected DNA molecules (6).
4.

In attempting to observe inhibition of the supercoiling reaction,
supercoiling was observed in samples containing pyridonecarboxylic
acid concentrations as high as the MBC, while no supercoiling
activity was observed in the absence or in the presence of low
concentrations of these drugs.

This indicates that the relaxing

activity of topo II' is greater than the supercoiling activity of
.ONA gyrase in my preparation and that this relaxing activity is
more sensitive to drug than

the

supercoiling activity.

At

concentrations as high as the MBC, topo II' is inhibited enough to
allow the supercoiling activity of DNA gyrase to be detected.

There may be contaminating proteases in my preparation that cleaves
the B subunit into a v-like subunit or the B subunit may be less stable
than the v-like subunit perhaps due to improper renaturation after urea
treatment.

However the B subunit is cleaved, it appears that it is
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cleaved in the portion of the protein that contains the ATPase activity
leaving the portion of the protein that interacts with the A subunit
intact.

If it could no longer interact with the A subunit, then the DNA

cleavage reaction most likely would not be observed since the A subunit
off. coli DNA gyrase does not cleave DNA in the absence of the B or v
subunit and site specific cleavage is observed in my preparation
(Figures 20, 22, and 35).
The activities of f. coli and P. aeruginosa DNA gyrase are also
similar.

E·

aeruginosa DNA gyrase supercoil relaxed closed circular DNA

in an ATP-dependent reaction (Figures 19 and 21).

It relaxes negatively

supercoiled ONA in the absence but not in the presence of ATP (Figure
24).

Also, incubating the enzyme with DNA and norfloxacin, nalidixic

acid, or oxolinic acid followed by incubation in the presence of SOS,
results in cleavage of DNA (Figure 35, lanes 3, 5, and 6, respectively).
Cleavage occurs in the presence and absence of ATP (lane 7) and AppNp (a
nonhydrolyzable analog of ATP,
pyridonecarboxylic acid

lane 8),

and

does

not occur if

is absent or if novobiocin (a B subunit

inhibitor) is used instead (lane 10).

E· aeruginosa DNA gyrase also

catentates closed circular DNA in the presence of spermidine and ATP
(Figure 34).

E· aeruginosa DNA gyrase is different from f. coli DNA

gyrase in that it has no detectable ATPase activity.

This may not be

real however since the supercoiling activity is very unstable and E.
coli DNA gyrase isolated using the same procedure has similar problems
with supercoiling in my system (Figure 18).

In fact, the two DNA

gyrases may not be different at all.
Since pyridonecarboxylic acids are inhibitors of the A subunit of
DNA gyrase (10,22,24) and inhibition of P. aeruginosa DNA gyrase
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catalyzed supercoiling by nalidixic acid and novobiocin has already been
shown (56), the relaxation activity was examined in detail. The Km for
relaxation is 1.1 +/- 0.5 x 10- 9 Molar (M). This relaxation activity
was inhibited by pyridonecarboxyl ic acids, but not novobiocin (Figure
17). The more potent derivative, norfloxacin, has a smaller Ki (2.0 x
10- 3 M) than the less potent oxolinic acid (K; = 3.7 x 10- 3 M).
Nalidixic acid, which is the least potent, has the largest Ki which is
10.8 x 10- 3 M. This indicates that the mechanism of action of
pyridonecarboxylic acids involves their inhibition of DNA gyrase, since
the more potent derivatives inhibit DNA gyrase to a greater extent.
Also, the more potent inhibitors of the supercoiling reaction have a
higher affinity for DNA (70).
The five fold difference in Ki's does not completely explain the
100 fold difference in the MIC's and MBC's.

The greater inhibition of

protein synthesis by nalidixic acid over norfloxacin may also contribute
to the lower potency of nalidixic acid as compared to norfloxacin
because inhibition of protein synthesis overcomes the bactericidal
activity of these drugs.
due· to

different

The difference in MIC's and MBC's may also be

efficiencies

of

transportation

into

the

cell,

differences in metabolism of the drugs, and possible toxic effects of
the metabolic products.

No matter how these drugs inhibit DNA gyrase,

either indirectly by binding to DNA or by inhibiting DNA gyrase
directly, the more potent inhibitors have a greater bactericidal
activity.
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MECHANISM OF INHIBITION OF DNA GYRASE

Pyridonecarboxylic acids act by binding to DNA (70). Therefore, by
increasing the concentration of DNA for a certain drug concentration at
a set volume, the ratio of drug bound per unit length of DNA will be
decreased. This will result in a lesser extent of inhibition of subunit
A activity at the higher substrate (DNA) concentrations. As can be seen
in Figures 27, 28, and 29, the relaxation reactions carried out at
higher

substrate

inhibition,

smaller

concentrations
1/v

values)

have
for

greater
the

same

velocities

(less

concentrations

of

pyridonecarboxylic acids.
In order to understand the mechanism of inhibition of DNA gyrase by
pyridonecarboxylic acids, the question of whether or not the drug ever
comes in actual physical contact with the enzyme must first be answered.
In other words, do these drugs inhibit DNA gyrase indirectly by
interacting with DNA or directly by forming a complex with DNA gyrase
and DNA? The binding experiments of Shen et

~·

(64) indicate that the

drug does not bind directly to£. coli DNA gyrase. However, cleavage of
DNA by DNA gyrase in the presence of SOS and drug, but not in the
absence of drug, suggests that the drug does eventually come in physical
contact with the enzyme.

The drug most likely traps a reaction

intermediate in which the enzyme is covalently attached to the DNA.
Also, oxolinic acid inhibits the specific binding of DNA gyrase to ort,
but does not inhibit the arbitrary binding spread throughout the rest of
the DNA molecule (50).

The data mentioned above suggest that the

inhibition of DNA gyrase by pyridonecarboxylic acids results from the
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initial binding of drug to DNA followed by physical contact of DNA
gyrase with the drug-DNA complex.
Since pyridonecarboxylic acids bind to the substrate (DNA) and not
the enzyme

(DNA gyrase),

it is unlikely that these drugs exert

noncompetitive or mixed inhibition on the relaxation reaction, because
noncompetitive inhibitors interfere with the catalytic properties of the
enzyme while having no effect on the binding of the substrate, and mixed
inhibitors bind both to the free enzyme and the enzyme substrate
complex.

Also, the inhibition exerted by noncompetitive inhibitors is

independent of the ratio of inhibitor concentration to substrate
concentration and increasing the substrate concentration causes a
decrease in the extent of inhibition for a given pyridonecarboxylic acid
concentration (Figures 27, 28, and 29).

Pyridonecarboxylic acids may

not exert uncompetitive inhibition on the relaxation reaction, because
uncompetitive inhibitors bind only to the enzyme-substrate complex, and
not to the free enzyme.

Since pyridonecarboxylic acids bind to

substrate in the absence of enzyme, their effects (if any) on the
association of enzyme and
uncompetitive inhibition.
these

drugs

would

be

substrate would

not be

considered

in

The most likely type of inhibition exerted by
the

competitive

type,

because

competitive

inhibitors exert their effect before the association of the enzyme and
substrate.
depends

on

Also, in competitive inhibition, the degree of inhibition
the

ratio

of

inhibitor

concentration

to

substrate

concentration and, as mentioned previously, decreasing this ratio causes
a decrease in the extent of inhibition.
I propose three models for the inhibition of DNA gyrase by
pyridonecarboxylic acids.

In the first model, DNA gyrase may supercoil
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or relax DNA at any site where it is bound, and the drug will prevent
this "twisting" whenever it is in contact with the enzyme (Figure 37A).
This inhibition would be uncompetitive and would only occur if drugbound DNA sites had no effect on the affinity and pattern of binding of
DNA gyrase to DNA.

Alternatively, DNA gyrase may only be able to

supercoil or relax specific

11

twistable 11 sites on the DNA, and this is

the basis of the second and third models.

The site specific cleavage of

DNA by DNA gyrase and the discovery of a full binding mode and an
incomplete binding mode of DNA gyrase to DNA (34A) supports this
assumption

(22,59,74).

In

the absence of drug,

DNA

gyrase may

translocate along the DNA molecule until it reaches a site that is
twistable.

In the second model, drug-bound sites on the DNA may block

this translocation and prevent the enzyme from reaching a twistable site
(Figure 378).

In the third model, DNA gyrase may have a higher affinity

for drug-bound sites than it does for twistable sites.

The presence of

enough drug bound sites wi 11 prevent the binding of DNA gyrase to
twistable

sites

(Figure 37C).

In

the

second and

third models,

pyridonecarboxyl ic acids would effect the association of enzyme and
substrate; thus, the inhibition would be competitive.
Cornish-Bowden plots of the inhibition of the relaxation reaction
by pyridonecarboxylic acids indicate competitve inhibition at high
substrate concentrations and uncompetitive inhibition at low.
results are in agreement with the third model.

These

At high substrate

concentrations, there will be less drug bound per unit length of DNA.
Thus, not a 11 of the twi stable sites wi 11 be bound by drug and drugbound DNA sites will compete with unbound twistable sites for DNA
gyrase. A DNA gyrase molecule which is trapped at a drug-bound DNA site
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Figure 37. Three Models of Pyridonecarboxylic Acid Inhibition of the
Pseudomonas aeruginosa DNA Gyrase Relaxation Reaction.
E = Pseudomonas aeruginosa DNA gyrase, S = supercoiled DNA, S* =
"twistable site, 11 D = pyridonecarboxylic acid. Double lines across the
arrows represent an inhibition of the reaction.
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which is not a twistable site is essentially inactivated.

If one

considers the drug-bound DNA and not the drug alone as the inhibitor,
this

type

of

inhibition

is

competitive.

At

low

substrate

concentrations, more drug will be bound per unit of length of DNA.

At

the substrate concentration when all of the twistable sites are bound by
drug,

the

inhibition

becomes

uncompetitive.

In

uncompetitive

inhibition, the inhibitor, which in this case is considered as the drug
alone, binds to the enzyme substrate complex and not the free enzyme.
In summary, the model

for the inhibition of the DNA gyrase

catalyzed relaxation reaction by pyridonecarboxylic acids is as follows.
This drug will bind to DNA forming a drug-DNA complex that competes with
unbound twistable DNA sites for DNA gyrase, thus resulting in a
competitive type inhibition. As the drug concentration is increased (or
the substrate concentration decreased), all of the twistable DNA sites
will be bound by drug and the inhibition will become uncompetitive.
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